WO2023281598A1 - Therapeutic device - Google Patents

Therapeutic device Download PDF

Info

Publication number
WO2023281598A1
WO2023281598A1 PCT/JP2021/025347 JP2021025347W WO2023281598A1 WO 2023281598 A1 WO2023281598 A1 WO 2023281598A1 JP 2021025347 W JP2021025347 W JP 2021025347W WO 2023281598 A1 WO2023281598 A1 WO 2023281598A1
Authority
WO
WIPO (PCT)
Prior art keywords
cover
stent graft
stent
graft
shaft
Prior art date
Application number
PCT/JP2021/025347
Other languages
French (fr)
Japanese (ja)
Inventor
邦生 桑原
英一 中野
悠暉 豊田
Original Assignee
日本ライフライン株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日本ライフライン株式会社 filed Critical 日本ライフライン株式会社
Priority to JP2023532897A priority Critical patent/JPWO2023281598A1/ja
Priority to PCT/JP2021/025347 priority patent/WO2023281598A1/en
Publication of WO2023281598A1 publication Critical patent/WO2023281598A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/962Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/962Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve
    • A61F2/966Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve with relative longitudinal movement between outer sleeve and prosthesis, e.g. using a push rod

Definitions

  • the present invention relates to a treatment device used for treatment of, for example, arterial dissection (dissecting aneurysm).
  • stents made of wires are placed in the affected area.
  • a method is used to expand and maintain the lumen of a tubular organ and prevent rupture of an aneurysm or the like.
  • stent-grafts which are provided with tubular grafts covering such stents, are used, for example, in the treatment of arterial dissection in blood vessels.
  • the OSG (Open Stent Graft) method has been proposed as one of the treatment methods for arterial dissection in the thoracic aorta.
  • the aorta is incised after thoracotomy, a stent graft is inserted through the incision, and the proximal end of the stent graft and the patient's blood vessel are anastomosed by suturing. is designed to anastomose another artificial blood vessel to this anastomosis.
  • a delivery catheter as disclosed in Patent Document 1 is used.
  • This catheter is adapted to mount (hold) a stent-graft whose diameter is reduced when the stent-graft is inserted through the above-described incision.
  • treatment devices such as catheters for delivery are generally required to improve convenience during treatment. Therefore, a proposal that can improve the convenience of such treatment is desired.
  • a treatment device includes a catheter having a shaft extending along the axial direction, a stent graft including a tubular graft and a stent, and a stent graft at the distal end region of the shaft.
  • first and second covers axially spaced apart from each other for retaining the reduced diameter condition.
  • the first cover is arranged axially proximal to the second cover.
  • the second cover has a cylindrical outer layer located on the outer peripheral side of the shaft, and the outer layer and the inner peripheral side of the shaft, and extends through the shaft to the proximal end side of the catheter. It has an inner layer portion and a folded portion connecting the outer layer portion and the inner layer portion on the distal end side of the shaft.
  • a stent graft is held in a reduced diameter state between the first cover and the shaft and between the outer layer of the second cover and the shaft, respectively.
  • the cover for holding the stent graft in a diameter-reduced state in the distal end region of the shaft is the first cover on the proximal end side along the axial direction.
  • the second cover on the distal end side along the axial direction.
  • the stent graft is held in the reduced diameter state between the first cover and the shaft and between the outer layer portion of the second cover and the shaft.
  • the radial stent-graft As the radial stent-graft is deployed from within the first and second covers and expanded, the following occurs. That is, the stent graft is pulled along the axial direction toward the vicinity of the boundary between the first and second covers (near the intermediate position of the stent graft). As a result, when the expanded stent graft is left in the patient's body, displacement of the indwelling position (positional displacement in the axial direction) of the stent graft is suppressed.
  • the first pulling operation which is an operation of pulling the proximal side of the first cover toward the proximal direction of the shaft
  • a second pulling operation which is an operation of pulling the proximal side of the catheter in the proximal direction of the catheter
  • the stent-grafts in the reduced diameter state are pulled from within the second and first covers, respectively, in this order. It may be adapted to be deployed and expanded in diameter. In this case, the deviation of the indwelling position of the stent graft described above can be more easily suppressed, and as a result, the convenience of the treatment can be further improved.
  • the stent graft may be partially provided with a window portion in which at least the graft of the graft and the stent is not arranged.
  • blood flows from the window to a bifurcation (for example, arch bifurcation) from a blood vessel (artery or the like) in which the stent graft is placed. Therefore, reconstruction treatment (anastomosis with an artificial blood vessel, etc.) for this bifurcated portion is not necessary, so that the operation time can be shortened and the invasiveness can be reduced during the treatment.
  • the tip of the window may be located near the boundary between the first and second covers.
  • the first and second covers are separated from each other as described above.
  • the stent-graft is pulled toward the boundary, the following is true. That is, since the tip of the window portion is positioned near such a boundary, when the expanded stent graft is placed in the patient's body, the window portion may be misaligned (displaced in the axial direction). ) is suppressed. As a result, convenience during treatment is further improved.
  • the cover for holding the stent graft in a diameter-reduced state at the distal end region of the shaft is arranged separately from the first and second covers.
  • FIG. 1 is a schematic diagram showing a schematic configuration example of a treatment apparatus according to an embodiment of the present invention
  • FIG. 2 is a schematic diagram showing an example of the detailed configuration inside the cover shown in FIG. 1, etc.
  • FIG. FIG. 2 is a schematic diagram showing a detailed configuration example of the stent graft shown in FIG. 1
  • FIG. 2 is a schematic diagram showing an example of how to use the treatment apparatus shown in FIG. 1
  • FIG. 4 is a schematic diagram showing an example of a method of placing a stent graft using a therapeutic device according to a comparative example
  • FIG. 4 is a schematic diagram showing an example of a method of placing a stent graft using a therapeutic device according to an embodiment
  • FIG. 10 is a schematic diagram showing a configuration example of a stent graft applied to a treatment device according to a modification;
  • FIG. 1 is a schematic side view showing an example of a schematic configuration of a therapeutic device (therapeutic device 4) according to an embodiment of the present invention.
  • the therapeutic device 4 is a device used for treatment of arterial dissection or the like using the OSG method, for example, and in this example, as shown in FIG. ing.
  • the stent graft 2 is designed to be indwelled in a site to be treated (for example, in a blood vessel such as an artery) using the catheter 1 during the treatment described above.
  • a catheter 1 is a medical device used when carrying a stent graft 2 to the site to be treated in a patient.
  • This catheter 1 as shown in FIG. 1, has a delivery shaft 11 and a handle 12 (grasping portion, grip).
  • the delivery shaft 11 corresponds to a specific example of "shaft" in the present invention.
  • the delivery shaft 11 is made of a flexible tubular structure (tubular member), and has a shape that extends (stretches) along the Z-axis direction, which is its own axial direction (longitudinal direction).
  • the stent graft 2 which will be described later, is held inside the cover 3, which will be described later, with its diameter reduced, as shown in FIG. It has become so.
  • the base end region of the delivery shaft 11 corresponds to the portion accommodated within the handle 12 .
  • the intermediate region between the distal end region and the proximal end region is a region located between the cover 3 and the handle 12 as shown in FIG. there is
  • the length (total length) along the axial direction of the delivery shaft 11 is, for example, about 300 to 900 mm, preferably about 400 to 800 mm, more preferably about 450 to 750 mm. , 670 mm.
  • the length of the tip region described above is appropriately set according to the length of the stent graft 2 to be mounted, and is, for example, about 30 to 300 mm, preferably about 50 to 270 mm, more preferably about 50 to 270 mm. It is about 80 to 250 mm.
  • the length of the intermediate region is, for example, approximately 100 to 600 mm, preferably approximately 150 to 550 mm, more preferably approximately 200 to 500 mm, and a preferred example is 260 mm.
  • the outer diameter of the tip region is, for example, about 5 to 20 mm, preferably about 8 to 15 mm, and a preferred example is 11 mm.
  • the outer diameter of the intermediate region is, for example, approximately 5 to 20 mm, preferably approximately 8 to 15 mm, and a preferred example is 10 mm.
  • the handle 12 is attached to the proximal end portion (base end region) of the delivery shaft 11, and is the portion that the operator (doctor) grasps (grips) when using the catheter 1.
  • the handle 12 has a shape extending along its axial direction (Z-axis direction).
  • the length of the handle 12 along the axial direction is, for example, about 50 to 200 mm, preferably about 60 to 180 mm, more preferably about 80 to 150 mm, and a preferred example is 130 mm.
  • the outer diameter of the handle 12 is, for example, approximately 3 to 30 mm, preferably approximately 5 to 25 mm, and a preferred example is 20 mm.
  • the handle 12 is made of synthetic resin such as polycarbonate or acrylonitrile-butadiene-styrene copolymer (ABS).
  • FIG. 2 is a side view schematically showing an example of the detailed configuration inside the cover 3 shown in FIG.
  • FIG. 3 schematically shows a detailed configuration example of the stent graft 2 shown in FIG.
  • the stent graft 2 as shown in FIGS. 1 and 3, has a tubular (cylindrical) structure extending along its axial direction (Z-axis direction), and includes a stent 21 and a graft 22. It is configured. Also, the stent graft 2 has a self-expanding structure that can be held in a reduced diameter state.
  • the axial length of the stent graft 2 is, for example, about 150 to 270 mm. Further, the outer diameter of the stent graft 2 when expanded is, for example, about 17 to 39 mm.
  • the stent 21 is configured using one or a plurality of wire rods W (element wires), and in this example has a tubular (cylindrical) structure.
  • this tubular structure is configured by a mesh structure, and such a tubular mesh structure is formed by braiding the wire W in a predetermined pattern.
  • the knitting pattern includes, for example, plain weave, twill weave, and knitting.
  • a cylindrical network structure may be formed by arranging one or more cylindrically processed wire rods W that are bent in a zigzag shape.
  • a metal wire rod is preferable, and in particular, a shape memory alloy, which is imparted with a shape memory effect and superelasticity by heat treatment, is preferably adopted.
  • a shape memory alloy which is imparted with a shape memory effect and superelasticity by heat treatment.
  • stainless steel, tantalum (Ta), titanium (Ti), platinum (Pt), gold (Au), tungsten (W), or the like may be used as the material of the wire W.
  • a wire W for example, a synthetic resin may be used.
  • the graft 22 has a tubular (cylindrical) shape as shown in FIGS. 1 and 3 and is arranged to cover (cover) at least a portion of the stent 21 .
  • the graft 22 is arranged so as to cover the inner peripheral side or the outer peripheral side of the stent 21 (wire W), or the graft 22 is arranged on the outer peripheral side and the inner peripheral side of the stent 21 (wire W). are arranged to cover both sides of the
  • a stent-arranged area A1 and a stent-unarranged area A2 are provided along the axial direction (Z-axis direction) of the stent graft 2, a stent-arranged area A1 and a stent-unarranged area A2 are provided.
  • the stent arrangement area A1 is located on the distal end side of the stent graft 2 and is an area where the stent 21 is arranged on the graft 22 (both the stent 21 and the graft 22 are present).
  • the non-stented region A2 is located on the proximal side of the stent graft 2 (the proximal side of the stented region A1), and is a region where the stent 21 is not placed on the graft 22 (only the graft 22 exists). is.
  • the axial length of the stent-arranged region A1 is, for example, about 130 to 250 mm
  • the axial length of the non-stent-arranged region A2 is, for
  • a portion of the stent graft 2 is provided with a window 20 in which at least the graft 22 of the graft 22 and the stent 21 is not arranged.
  • a portion of the stent placement region A1 is provided with a window 20 in which the graft 22 is not placed (the stent 21 is exposed to the outside from the graft 22).
  • the window 20 has a substantially rectangular shape with a long axis along the axial direction (Z-axis direction) of the stent graft 2 .
  • the length of the window portion 20 in the major axis direction is, for example, about 50 to 100 mm
  • the length of the window portion 20 in the minor axis direction is, for example, The length is about 30 to 50% of the outer peripheral length of the stent graft 2 .
  • the length from the end of the window 20 on the side of the non-stented region A2 to the boundary position between the non-stented region A1 and the non-stented region A2 is, for example, about 20 mm.
  • the length from the end of the window 20 opposite to the non-stented region A2 to the end of the stent graft 2 is, for example, about 60 to 150 mm.
  • the graft 22 is connected to the stent 21 by means of sewing, adhesion, welding, or the like.
  • the graft 22 covers and connects the stent 21 so as not to affect the expansion and contraction of the stent 21 .
  • connecting portions between the graft 22 and the stent 21 are appropriately provided, for example, at both end portions or an intermediate portion of the stent 21 .
  • thermoplastic resin is formed into a tubular shape by a molding method such as extrusion molding or blow molding, or a knitted or woven fabric made of thermoplastic resin fibers or ultrafine metal wires formed into a tubular shape.
  • a molding method such as extrusion molding or blow molding
  • a knitted or woven fabric made of thermoplastic resin fibers or ultrafine metal wires formed into a tubular shape.
  • Cylindrical nonwoven fabrics made of thermoplastic resin or ultra-fine metal, Cylindrical flexible resin sheets or porous sheets, Solvent-dissolved resin formed into thin cylinders by electrospinning structure, etc. can be used.
  • thermoplastic resin fibers formed in a cylindrical shape and furthermore, plain weave fabrics of thermoplastic resin fibers formed in a cylindrical shape are excellent in strength, porosity, and productivity. can be said to be preferable.
  • thermoplastic resins examples include polyolefins such as polyethylene, polypropylene, and ethylene- ⁇ -olefin copolymers, polyamides, polyurethanes, polyethylene terephthalate, polybutylene terephthalate, polycyclohexane terephthalate, polyethylene-2,6-naphthalate, and the like.
  • polyester, fluororesin such as polyethylene fluoride and polypropylene fluoride, and other resins with less durability and tissue reaction can be used.
  • polyesters such as polyethylene terephthalate, and fluororesins such as polyethylene fluoride and polypropylene fluoride, which are chemically stable, highly durable, and less prone to tissue reaction, can be preferably used.
  • the cover 3 is a member for holding the stent graft 2 in a diameter-reduced state in the distal region of the delivery shaft 11 .
  • the stent graft 2 is adapted to be retained within the cover 3 .
  • the outer diameter of the cover 3 is, for example, approximately 5.0 to 20.0 mm, preferably approximately 7.5 to 18.0 mm, and a preferred example is 13.0 mm.
  • Such a cover 3 is composed of a soft cover in this example.
  • a soft cover By covering the stent graft 2 in a diameter-reduced state with a soft cover, the stent graft 2 can be reliably held. Further, since the cover 3 is soft, it is possible for the cover 3 to easily follow changes in the shape of the distal end region of the delivery shaft 11 compared to a hard tubular body (sheath) or the like. .
  • the cover 3 of the present embodiment includes two types of covers (covers 31 , 32).
  • the cover 31 is arranged on the base end side of the cover 32 along the axial direction
  • the cover 32 is arranged on the distal end side of the cover 31 along the axial direction.
  • cover 31 corresponds to a specific example of the "first cover” in the present invention.
  • cover 32 corresponds to a specific example of the "second cover” in the present invention.
  • the cover 31 has a cylindrical structure extending along the axial direction.
  • the axial length of the cover 31 is, for example, about 30 to 150 mm.
  • the cover 32 has a two-layer structure (double structure) having an inner layer portion 321 and an outer layer portion 322, as shown in FIGS.
  • the cover 32 has a tubular outer layer portion 322 and an inner layer portion 321 located on the inner peripheral side of the outer layer portion 322 .
  • the outer layer portion 322 is positioned on the outer peripheral side of the delivery shaft 11 and the inner layer portion 321 is positioned on the inner peripheral side of the delivery shaft 11 .
  • the cover 32 is provided with a folded portion 323 which is a portion that connects (connects) the outer layer portion 322 and the inner layer portion 321 at the distal end side of the delivery shaft 11 (see FIGS. 1 and 2). reference).
  • the cover 32 is formed by folding a cylindrical tube member inward, and the folded portion corresponds to the inner layer portion 321 . 1 and 2, the proximal side of the inner layer portion 321 extends to the proximal side of the catheter 1 through the inside of the delivery shaft 11. As shown in FIGS. Specifically, as shown in FIG. 1 , the proximal side of the inner layer portion 321 is inserted through the insides of the delivery shaft 11 and the handle 12 , respectively, and protrudes from the proximal side of the handle 12 .
  • the stent graft 2 is placed between the cover 31 and the delivery shaft 11 (between the layers) and between the outer layer portion 322 of the cover 32 and the delivery shaft 11 in the diameter-reduced state described above. , is held (see arrow P0).
  • the tip of the window 20 in such a diameter-reduced state, is positioned near the boundary Pb between the covers 31 and 32. .
  • the stent graft 2 is held in a diameter-reduced state within these covers 31 and 32 so that the tip of the window 20 in the stent graft 2 is positioned near the boundary Pb between the covers 31 and 32.
  • the cover 31 and the cover 32 are each made of, for example, a material exhibiting translucency or transparency (optical transparency).
  • translucent or transparent materials include polyolefins such as polyethylene, polypropylene, and ethylene- ⁇ -olefin copolymers, polyamides, polyimides, polyurethanes, polyethylene terephthalate, polybutylene terephthalate, polycyclohexane terephthalate, Polyester such as polyethylene-2,6-naphthalate, fluorine resin such as polyethylene fluoride and polypropylene fluoride, woven fabric or knitted fabric made of fibers of resin such as silicone, or structure such as film or sheet, or a combination thereof things, etc.
  • the members constituting the cover 3 (covers 31 and 32) described above may be those which are manufactured in advance into a tubular shape using the above-mentioned materials, or those which are flattened into a tubular shape, or those which are formed into a tubular shape. The thing which consists of a combination, etc. are mentioned.
  • the stent graft 2 is expanded by pulling the covers 31 and 32, which will be described later.
  • the details of the operation for expanding the stent graft 2 (the method of placing the stent graft 2 during treatment) will be described later (FIG. 6).
  • the treatment device 4 of the present embodiment is used, for example, for treatment of arterial dissection and the like.
  • the operator manipulates the catheter 1 to carry the stent graft 2 in a reduced diameter state to a site to be treated (for example, inside a blood vessel such as an artery) in a patient, and then indwell it after being expanded. .
  • a site to be treated for example, inside a blood vessel such as an artery
  • the stent graft 2 is used, for example, in treatment using the OSG method, which is one of treatment methods such as arterial dissection in the thoracic aorta.
  • FIG. 4 is a schematic diagram showing an example of how to use the treatment device 4 during such treatment.
  • the artery 9 thoracic aorta
  • the distal arch aorta the portion of the arch bifurcation 9B shown in FIG. 4
  • the proximal descending aorta will be described as an example.
  • a portion of the artery 9 is incised using the therapeutic device 4 configured as shown in FIGS.
  • the stent graft 2 in a reduced diameter state is inserted through the opening (see arrow P8). Specifically, the stent graft 2 is inserted from the distal end side (cover 3 side) of the delivery shaft 11 in the catheter 1 . At this time, for example, as shown in FIGS. 1 and 2, the stent graft 2 is held inside the cover 3 at the distal end region of the delivery shaft 11 of the catheter 1 in a reduced diameter state.
  • the catheter 1 is inserted along a predetermined guide wire in order to avoid the risk of the catheter 1 being erroneously inserted into the false lumen 9F. That is, the catheter 1 is inserted while inserting such a guide wire into the lumen of the catheter 1 .
  • a guide wire is inserted into the artery 9 from the patient's groin (groin), passed through the artery 9, and pulled out from the opening described above. Since the guidewire is inserted into the artery 9 from the peripheral side, the guidewire is reliably inserted into the true lumen 9T without being mistakenly inserted into the false lumen 9F.
  • the length of such a guide wire is, for example, approximately 50 to 450 cm, and its outer diameter is, for example, approximately 0.2 to 1.0 mm.
  • the catheter 1 is inserted into the artery 9 along the guide wire using the opening as an entrance (see arrow P8).
  • the catheter 1 since the guide wire is surely inserted into the true lumen 9T, by inserting the catheter 1 into the artery 9 along the guide wire, the catheter 1 can also be reliably inserted. is inserted into the true lumen 9T. That is, even in the case of arterial dissection, the risk of the catheter 1 being inserted into the false lumen 9F is avoided.
  • the treatment device 4 is used to allow the stent graft 2 to reach a site in the artery 9 beyond the site to be treated (near the aneurysm formation site) (see arrow P8). ).
  • the diameter of the stent graft 2 is expanded (deployed). Specifically, first, the operator of the catheter 1 performs a pulling operation (an operation of pulling toward the proximal end) with respect to the covers 31 and 32, which will be described later. Then, the covers 31 and 32 are removed from the stent graft 2, details of which will be described later. As a result, this stent graft 2 gradually expands due to the self-expanding force of the stent 21 .
  • the stent graft 2 is fixed to the inner wall of the artery 9 as shown in FIG. 4, for example.
  • the lumen of artery 9 near the site of aneurysm formation is dilated and retained.
  • the proximal end side of the stent graft 2 (the graft 22 in the non-stented region A2) and the artery 9 (vessel of the patient) are sutured to form an anastomosis.
  • an artificial blood vessel 90 other than the stent graft 2 may be anastomosed with the anastomosis portion, if necessary.
  • the inner periphery of the aneurysm is covered with the stent graft 2, allowing blood flow to pass through the stent graft 2 (see arrow P91 in FIG. 4) and flow into the cleft in the inner wall of the blood vessel (false lumen 9F).
  • blood pressure and the like cease to act on the aneurysm. Therefore, enlargement of the aneurysm diameter and rupture of the blood vessel can be prevented.
  • the OSG method omits the anastomosis between the distal end of the stent graft 2 and the descending aorta, thereby simplifying the anastomosis.
  • this OSG method has the advantage that the grafting range of the artificial blood vessel can be set in a wide range, and surgical treatment of nearby complications is also possible.
  • the stent graft applied to the OSG method is not introduced from the groin as in the above-described conventional treatment method, there is no need to pass through a thin blood vessel, and the outer diameter can be reduced to some extent even when the diameter is reduced. Even if it is big (thick), it is good.
  • FIG. 5 schematically shows an example of a placement method of the stent graft 2 when using a therapeutic device (therapeutic device 104) according to a comparative example.
  • FIG. 6 schematically shows an example of a placement method of the stent graft 2 in the case of using the therapeutic device 4 of the present embodiment. 5 and 6 also show the insertion direction (arrow P8) of the catheter 1 into the artery 9 described above with reference to FIG.
  • the operator of the catheter 1 pulls the proximal end of the cover 103 toward the proximal end of the delivery shaft 11 (see arrow P101). .
  • the stent graft 2 in a diameter-reduced state is pulled by the self-expanding force of the stent 21, as shown in FIGS. It expands sequentially from the inside and expands in diameter (see arrow P102).
  • the stent graft 2 is gradually deployed from the distal end side to the proximal end side to expand its diameter.
  • FIG. 5(C) the entire stent graft 2 is finally deployed and expanded in diameter.
  • the operator of the catheter 1 pulls the proximal side of the inner layer 321 of the cover 32 toward the proximal direction of the catheter 1 (second pulling). operation) is performed (see arrow P12).
  • second pulling operation
  • the outer layer portion 322 of the cover 32 is pulled into the delivery shaft 11 via the folded portion 323 (see arrow P120), and the catheter 1 is pulled. It will be gradually pulled proximally.
  • the stent graft 2 in a diameter-reduced state is sequentially expanded from within the cover 32 by the self-expanding force of the stent 21 and expands in diameter (see arrow P2).
  • the stent graft 2 is gradually deployed from the distal end side to the proximal end side (near the boundary Pb between the covers 31 and 32 in this example) and expands in diameter.
  • the operator of the catheter 1 pulls the proximal side of the cover 31 toward the proximal end of the delivery shaft 11 (first pulling operation). (see arrow P11). That is, in the example shown in FIG. 6, the pulling operation (first pulling operation) for the cover 31 is started after the above-described pulling operation (second pulling operation) for the cover 32 is started.
  • the cover 31 By also performing such a pulling operation on the cover 31, as shown in FIGS. They are also successively expanded from inside the cover 31 to expand in diameter (see arrow P2). Specifically, in this example, the portion of the stent graft 2 on the proximal side (the proximal side of the boundary Pb described above) is gradually deployed from the distal side toward the proximal side and expands in diameter. .
  • the entire stent graft 2 (the entire area including the window 20) is finally deployed and expanded in diameter.
  • the cover 3 for holding the stent graft 2 in a diameter-reduced state in the distal end region of the delivery shaft 11 includes two types of covers (the proximal cover 31 and the distal end cover 31). It is axially separated on the side cover 32). The stent graft 2 is held in a diameter-reduced state between the cover 31 and the delivery shaft 11 and between the outer layer portion 322 of the cover 32 and the delivery shaft 11 .
  • the treatment is as follows. That is, during such treatment, an operation of pulling the proximal side of the cover 31 toward the proximal direction of the delivery shaft 11 and pulling the proximal side of the inner layer portion 321 of the cover 32 toward the proximal direction of the catheter 1 is performed.
  • the diameter-reduced stent graft 2 is expanded from the covers 31 and 32 by (pulling operation)
  • the following occurs. That is, the stent graft is pulled along the axial direction toward the vicinity of the boundary Pb between the covers 31 and 32 (near the intermediate position of the stent graft 2).
  • the diameter-reduced stent graft 2 is expanded from the covers 31 and 32 to expand its diameter.
  • first and second pulling operations as the pulling operations in this way, when the diameter-reduced stent graft 2 is deployed from the covers 31 and 32 and expanded in diameter, the above-mentioned In this way, it is possible to suppress the displacement of the indwelling position of the stent graft 2 .
  • the above-described first pulling operation is started after the above-described second pulling operation is started, so that the diameter-reduced stent graft 2 is pulled from inside the covers 31 and 32, respectively. They are deployed and expanded in this order.
  • the displacement of the indwelling position of the stent graft 2 described above can be more easily suppressed, and as a result, convenience during treatment can be further improved.
  • the stent graft 2 is partially provided with the window 20 in which at least the graft 22 out of the graft 22 and the stent 21 is not arranged. That is, for example, as shown in FIG. 4 described above, the window portion 20 (in the example of FIG. 4, the window portion 20), blood flows (see arrow P92 in FIG. 4).
  • blood in addition to the inside of the blood vessel (artery 9, etc.) in which the stent graft 2 is indwelled (see arrow P91 in FIG. 4), blood can also flow through the window 20 to the arch branch 9B. become. Therefore, reconstruction treatment (anastomosis with an artificial blood vessel, etc.) for this bifurcated portion becomes unnecessary, so that it is possible to shorten the operation time and reduce invasiveness during treatment.
  • the tip of the window portion 20 in the stent graft 2 in a diameter-reduced state, the tip of the window portion 20 is positioned near the boundary Pb between the covers 31 and 32, so the following is the case. That is, when the diameter-reduced stent graft 2 is deployed from within the covers 31 and 32 and expanded in diameter by the above-described pulling operations (the first and second pulling operations), The stent graft 2 will be pulled. Therefore, since the tip of the window 20 is positioned near the boundary Pb, the position of the window 20 may shift (position in the axial direction) when the expanded stent graft 2 is placed in the patient's body. deviation) is suppressed. As a result, it is possible to further improve the convenience of treatment.
  • FIG. 7 schematically shows a configuration example of a stent graft (stent graft 2A according to a modification) applied to a therapeutic device according to a modification.
  • the therapeutic device of this modified example is also a device that is used, for example, in the treatment of arterial dissection using the OSG method.
  • the treatment apparatus of this modification is provided with a stent graft 2A described below instead of the stent graft 2 in the treatment apparatus 4 of the embodiment, and has other configurations (each configuration of the catheter 1 and the cover 3). The same is true for
  • the stent graft 2A of this modification corresponds to the stent of the embodiment (see FIG. 3, etc.) in which the window 20 is not provided in the stent placement region A1.
  • Other configurations are the same. That is, in this stent graft 2A, unlike the stent graft 2, the stent 21 is not exposed from the graft 22 in the entire area of the stent arrangement area A1.
  • the configuration (shape, arrangement position, size, number, material, etc.) of each member described in the above embodiments and the like is not limited, and other shapes, arrangement positions, sizes, number, materials, etc. may be used. good.
  • specific configuration examples of the covers 31 and 32 have been described. etc.
  • the cover 31 may have a two-layer structure similar to the cover 32, having an outer layer portion, an inner layer portion, and a folded portion.
  • the present invention is not limited to this example. That is, if the covers 31 and 32 are arranged apart from each other along the axial direction, the ends of these covers 31 and 32 may partially overlap along the axial direction. .
  • the present invention is not limited to this case. That is, for example, the inner layer portion and the outer layer portion of the cover are separated from each other, and the inner layer portion and the outer layer portion are connected (connected) by the separate folding portion (connecting portion). You may do so.
  • the case where the distal end of the window portion 20 is positioned near the boundary Pb between the covers 31 and 32 in the stent graft in a diameter-reduced state has been described as an example. is not limited. That is, for example, the diameter-reduced stent graft may be arranged so that the tip of the window portion 20 is not positioned near such a boundary Pb.
  • the window portion 20 in which the graft 22 is not arranged is provided in a part of the stent graft 2 (stent arrangement region A1) has been described. Examples are not limited. That is, for example, a window portion in which neither the graft 22 nor the stent 21 is arranged may be provided in a part of the stent arrangement region A1 or the stent non-arrangement region A2.
  • the stent graft is provided with one stent-arranged region arranged on the distal end side within the cover and a non-stent-arranged region arranged on the proximal end side within the cover.
  • another non-stented region may be further provided on the distal end side of the stented region of the stent graft.
  • the stent-placed region may be sandwiched between two non-stented regions.
  • the stent graft placement method using the therapeutic device has been described with specific examples. Not limited. Specifically, for example, in the above embodiment and the like, after the pulling operation (second pulling operation) on the proximal side of the inner layer portion 321 of the cover 32 is started, the pulling operation (second pulling operation) on the proximal side of the cover 31 is performed. 1 pulling operation) has been described, but the present invention is not limited to this example. That is, for example, the first and second pulling operations are performed in parallel, respectively, or conversely, depending on the case, the second pulling operation is performed after the first pulling operation is started. An operation may be initiated.
  • the therapeutic device is configured by the catheter, the stent graft, and the cover has been described as an example, but the present invention is not limited to this. That is, for example, the therapeutic device may be configured with only the catheter, the therapeutic device with the catheter and the stent graft, or the therapeutic device with the catheter and the cover.
  • treatment devices catheters, stent grafts, covers, etc.
  • thoracic aorta including the distal arch aorta and the proximal descending aorta
  • the treatment apparatus of the present invention can also be applied to treatment of blood vessels such as other arteries (for example, ascending aorta, thoracoabdominal aorta, abdominal aorta, iliac artery, femoral artery, etc.). is.

Abstract

A therapeutic device according to one embodiment of the present invention comprises: a catheter having a shaft that extends in the axial direction; a stent graft that is configured by including a cylindrical graft and a stent; and first and second covers that are for holding the stent graft in a reduced-diameter state in a leading-end region of the shaft and that are disposed so as to be separated from each other along the axial direction. The first cover is disposed on a base-end side of the second cover along the axial direction. The second cover has: a cylindrical outer layer portion situated on the outer circumferential side of the shaft; an inner layer portion that is disposed on the inner circumferential side of the shaft and the outer layer portion and that extends up to the base-end side of the catheter through the interior of the shaft; and a fold-back portion that connects the outer layer portion and the inner layer portion on the leading-end side of the shaft. The stent graft is so configured as to be held in a reduced-diameter state between the first cover and the shaft and between the shaft and the outer layer portion of the second cover.

Description

治療装置therapy equipment
 本発明は、例えば動脈解離(解離性の動脈瘤)等の治療の際に用いられる治療装置に関する。 The present invention relates to a treatment device used for treatment of, for example, arterial dissection (dissecting aneurysm).
 近年、血管や生体内の他の管状器官に狭窄や閉塞が起こった場合や、血管に解離性の動脈瘤等が生じた場合に、線材(素線)などからなるステントをその患部に留置することで、管状器官の管腔を拡張・保持したり、動脈瘤等の破裂を防止することを可能とする手法(ステント留置術)が用いられている。特に、例えば血管における動脈解離等の治療の際には、そのようなステントを覆う筒状のグラフトが設けられた、ステントグラフトが用いられる。 In recent years, when stenosis or occlusion occurs in blood vessels or other tubular organs in the body, or when dissecting aneurysms occur in blood vessels, stents made of wires (elemental wires) are placed in the affected area. Thus, a method (stent placement) is used to expand and maintain the lumen of a tubular organ and prevent rupture of an aneurysm or the like. In particular, stent-grafts, which are provided with tubular grafts covering such stents, are used, for example, in the treatment of arterial dissection in blood vessels.
 ところで、最近では、胸部大動脈における動脈解離等の治療方法の1つとして、OSG(Open Stent Graft)法が提案されている。このOSG法では、開胸後に大動脈を切開し、その切開部からステントグラフトを挿入するとともに、そのステントグラフトの基端側と患者の血管とを縫合することで吻合し、更に必要に応じてこのステントグラフトとは別の人工血管をこの吻合部分と吻合するようになっている。 By the way, recently, the OSG (Open Stent Graft) method has been proposed as one of the treatment methods for arterial dissection in the thoracic aorta. In this OSG method, the aorta is incised after thoracotomy, a stent graft is inserted through the incision, and the proximal end of the stent graft and the patient's blood vessel are anastomosed by suturing. is designed to anastomose another artificial blood vessel to this anastomosis.
 また、このようなOSG法を利用した手技では、例えば特許文献1に開示されているようなデリバリ用のカテーテルが用いられる。このカテーテルには、上記した切開部からステントグラフトを挿入する際に、縮径された状態のステントグラフトがマウント(保持)されるようになっている。 In addition, in a procedure using such an OSG method, a delivery catheter as disclosed in Patent Document 1, for example, is used. This catheter is adapted to mount (hold) a stent-graft whose diameter is reduced when the stent-graft is inserted through the above-described incision.
特許第4494144号公報Japanese Patent No. 4494144
 ところで、このようなデリバリ用のカテーテル等の治療装置では一般に、治療の際の利便性を向上させることが求められている。したがって、このような治療の際の利便性を向上させることを可能とする提案が望まれる。 By the way, treatment devices such as catheters for delivery are generally required to improve convenience during treatment. Therefore, a proposal that can improve the convenience of such treatment is desired.
 治療の際の利便性を向上させることが可能な治療装置を提供することが望ましい。 It is desirable to provide a treatment device that can improve convenience during treatment.
 本発明の一実施の形態に係る治療装置は、軸方向に沿って延在するシャフトを有するカテーテルと、筒状のグラフトとステントとを含んで構成されたステントグラフトと、シャフトの先端領域においてステントグラフトを縮径状態にて保持するためのものであり、軸方向に沿って互いに分離配置されている第1および第2のカバーと、を備えている。第1のカバーは、軸方向に沿って第2のカバーの基端側に配置されている。第2のカバーは、シャフトの外周側に位置する筒状の外層部と、外層部およびシャフトの内周側に位置しており、シャフト内を介してカテーテルの基端側まで延在している内層部と、シャフトの先端側において外層部と内層部とを繋ぐ折り返し部と、を有している。第1のカバーとシャフトとの間、および、第2のカバーにおける外層部とシャフトとの間にそれぞれ、ステントグラフトが縮径状態で保持されるようになっている。 A treatment device according to one embodiment of the present invention includes a catheter having a shaft extending along the axial direction, a stent graft including a tubular graft and a stent, and a stent graft at the distal end region of the shaft. first and second covers axially spaced apart from each other for retaining the reduced diameter condition. The first cover is arranged axially proximal to the second cover. The second cover has a cylindrical outer layer located on the outer peripheral side of the shaft, and the outer layer and the inner peripheral side of the shaft, and extends through the shaft to the proximal end side of the catheter. It has an inner layer portion and a folded portion connecting the outer layer portion and the inner layer portion on the distal end side of the shaft. A stent graft is held in a reduced diameter state between the first cover and the shaft and between the outer layer of the second cover and the shaft, respectively.
 本発明の一実施の形態に係る治療装置では、上記シャフトの先端領域において上記ステントグラフトを縮径状態にて保持するためのカバーが、上記軸方向に沿って基端側の上記第1のカバーと、上記軸方向に沿って先端側の上記第2のカバーとに、分離配置されている。また、上記第1のカバーと上記シャフトとの間、および、上記第2のカバーにおける上記外層部と上記シャフトとの間にそれぞれ、上記ステントグラフトが上記縮径状態で保持されている。これにより、第1のカバーにおける基端側をシャフトの基端方向へと引っ張ると共に、第2のカバーの内層部における基端側をカテーテルの基端方向へと引っ張る操作(引っ張り操作)によって、縮径状態のステントグラフトが第1および第2のカバー内から展開されて拡径する際に、以下のようになる。すなわち、第1および第2のカバー同士の境界付近(ステントグラフトにおける中間位置付近)へ向けて、上記軸方向に沿ってステントグラフトが引っ張られることになる。その結果、拡径されたステントグラフトが患者体内に留置される際に、ステントグラフトの留置位置のずれ(軸方向への位置ずれ)が、抑制される。 In the treatment apparatus according to one embodiment of the present invention, the cover for holding the stent graft in a diameter-reduced state in the distal end region of the shaft is the first cover on the proximal end side along the axial direction. , and the second cover on the distal end side along the axial direction. The stent graft is held in the reduced diameter state between the first cover and the shaft and between the outer layer portion of the second cover and the shaft. As a result, the proximal side of the first cover is pulled in the proximal direction of the shaft, and the proximal side of the inner layer of the second cover is pulled in the proximal direction of the catheter (pulling operation). As the radial stent-graft is deployed from within the first and second covers and expanded, the following occurs. That is, the stent graft is pulled along the axial direction toward the vicinity of the boundary between the first and second covers (near the intermediate position of the stent graft). As a result, when the expanded stent graft is left in the patient's body, displacement of the indwelling position (positional displacement in the axial direction) of the stent graft is suppressed.
 本発明の一実施の形態に係る治療装置では、上記第1のカバーにおける基端側をシャフトの基端方向へと引っ張る操作である、第1の引っ張り操作と、上記第2のカバーの内層部における基端側をカテーテルの基端方向へと引っ張る操作である、第2の引っ張り操作と、がそれぞれ行われることによって、縮径状態のステントグラフトが、上記第1および第2のカバー内からそれぞれ展開されて、拡径するようになっていてもよい。このようにした場合、上記引っ張り操作としての上記第1および第2の引っ張り操作がそれぞれ行われることによって、縮径状態のステントグラフトが第1および第2のカバー内から展開されて拡径する際に、上記したようにして、ステントグラフトの留置位置のずれが抑制されることになる。 In the treatment apparatus according to one embodiment of the present invention, the first pulling operation, which is an operation of pulling the proximal side of the first cover toward the proximal direction of the shaft, and the inner layer portion of the second cover and a second pulling operation, which is an operation of pulling the proximal side of the catheter in the proximal direction of the catheter, so that the stent-grafts in a reduced diameter state are deployed from inside the first and second covers, respectively. It may be arranged such that it expands in diameter. In this case, when the diameter-reduced stent graft is deployed from inside the first and second covers and expanded by performing the first and second pulling operations as the pulling operations, respectively. , the displacement of the indwelling position of the stent graft is suppressed as described above.
 この場合において、上記第2の引っ張り操作が開始された後に上記第1の引っ張り操作が開始されることによって、縮径状態のステントグラフトが、上記第2および第1のカバー内からそれぞれ、この順序にて展開され、拡径されるようになっていてもよい。このようにした場合、上記したステントグラフトの留置位置のずれが、更に抑制され易くなる結果、治療の際の利便性が更に向上することになる。 In this case, by starting the first pulling operation after starting the second pulling operation, the stent-grafts in the reduced diameter state are pulled from within the second and first covers, respectively, in this order. It may be adapted to be deployed and expanded in diameter. In this case, the deviation of the indwelling position of the stent graft described above can be more easily suppressed, and as a result, the convenience of the treatment can be further improved.
 また、本発明の一実施の形態に係る治療装置では、上記ステントグラフトの一部に、グラフトおよびステントのうちの少なくともグラフトが配置されていない、窓部が設けられているようにしてもよい。このようにした場合、例えば、ステントグラフトが留置される血管(動脈等)からの分岐部分(例えば、弓部分岐)に対しても、上記窓部から血液が流れるようになる。したがって、この分岐部分の再建処置(人工血管との吻合処置等)が不要となるため、治療の際の手術時間の短縮化や、侵襲の低減が図られることになる。 In addition, in the therapeutic device according to one embodiment of the present invention, the stent graft may be partially provided with a window portion in which at least the graft of the graft and the stent is not arranged. In this case, for example, blood flows from the window to a bifurcation (for example, arch bifurcation) from a blood vessel (artery or the like) in which the stent graft is placed. Therefore, reconstruction treatment (anastomosis with an artificial blood vessel, etc.) for this bifurcated portion is not necessary, so that the operation time can be shortened and the invasiveness can be reduced during the treatment.
 この場合において、上記縮径状態のステントグラフトにおいて、上記窓部の先端が、上記第1および第2のカバー同士の境界付近に位置しているようにしてもよい。このようにした場合、上記した引っ張り操作によって、縮径状態のステントグラフトが第1および第2のカバー内から展開されて拡径する際に、上記したように、第1および第2のカバー同士の境界付近へ向けてステントグラフトが引っ張られることから、以下のようになる。すなわち、このような境界付近に上記窓部の先端が位置していることから、拡径されたステントグラフトが患者体内に留置される際に、上記窓部の位置ずれ(上記軸方向への位置ずれ)が、抑制される。その結果、治療の際の利便性が更に向上することになる。 In this case, in the diameter-reduced stent graft, the tip of the window may be located near the boundary between the first and second covers. In this case, when the diameter-reduced stent graft is expanded from within the first and second covers by the above-described pulling operation, the first and second covers are separated from each other as described above. As the stent-graft is pulled toward the boundary, the following is true. That is, since the tip of the window portion is positioned near such a boundary, when the expanded stent graft is placed in the patient's body, the window portion may be misaligned (displaced in the axial direction). ) is suppressed. As a result, convenience during treatment is further improved.
 本発明の一実施の形態に係る治療装置によれば、上記シャフトの先端領域において上記ステントグラフトを縮径状態にて保持するためのカバーが、上記第1および第2のカバーに分離配置されているようにしたので、患者体内でのステントグラフトの留置位置のずれを、抑制することができる。よって、そのような第1および第2のカバーを備えた治療装置を用いて治療を行うことで、治療の際の利便性を向上させることが可能となる。 According to the therapeutic device according to one embodiment of the present invention, the cover for holding the stent graft in a diameter-reduced state at the distal end region of the shaft is arranged separately from the first and second covers. As a result, displacement of the placement position of the stent graft within the patient's body can be suppressed. Therefore, by performing treatment using a treatment apparatus having such first and second covers, it is possible to improve the convenience of treatment.
本発明の一実施の形態に係る治療装置の概略構成例を表す模式図である。1 is a schematic diagram showing a schematic configuration example of a treatment apparatus according to an embodiment of the present invention; FIG. 図1に示したカバー内部の詳細構成例等を表す模式図である。2 is a schematic diagram showing an example of the detailed configuration inside the cover shown in FIG. 1, etc. FIG. 図1に示したステントグラフトの詳細構成例を表す模式図である。FIG. 2 is a schematic diagram showing a detailed configuration example of the stent graft shown in FIG. 1; 図1に示した治療装置の使用方法の一例を表す模式図である。FIG. 2 is a schematic diagram showing an example of how to use the treatment apparatus shown in FIG. 1; 比較例に係る治療装置を用いた場合におけるステントグラフトの留置方法の一例を表す模式図である。FIG. 4 is a schematic diagram showing an example of a method of placing a stent graft using a therapeutic device according to a comparative example; 実施の形態に係る治療装置を用いた場合におけるステントグラフトの留置方法の一例を表す模式図である。FIG. 4 is a schematic diagram showing an example of a method of placing a stent graft using a therapeutic device according to an embodiment; 変形例に係る治療装置に適用されるステントグラフトの構成例を表す模式図である。FIG. 10 is a schematic diagram showing a configuration example of a stent graft applied to a treatment device according to a modification;
 以下、本発明の実施の形態について、図面を参照して詳細に説明する。なお、説明は以下の順序で行う。
1.実施の形態(互いに分離配置された2種類のカバーを有する治療装置の例)
2.変形例(治療装置に適用されるステントグラフトの他の構成例)
3.その他の変形例
BEST MODE FOR CARRYING OUT THE INVENTION Hereinafter, embodiments of the present invention will be described in detail with reference to the drawings. The description will be given in the following order.
1. Embodiment (example of therapeutic device having two types of covers arranged separately from each other)
2. Modification (another configuration example of a stent graft applied to a therapeutic device)
3. Other variations
<1.実施の形態>
[概略構成]
 図1は、本発明の一実施の形態に係る治療装置(治療装置4)の概略構成例を、模式的に側面図で表したものである。治療装置4は、例えばOSG法を利用した動脈解離等の治療の際に用いられる装置であり、この例では図1に示したように、カテーテル1(デリバリカテーテル)、ステントグラフト2およびカバー3を備えている。なお、このステントグラフト2は、詳細は後述するが、例えば上記した治療の際に、カテーテル1を用いて、治療対象の部位(例えば動脈等の血管内)に留置されるようになっている。
<1. Embodiment>
[Outline configuration]
FIG. 1 is a schematic side view showing an example of a schematic configuration of a therapeutic device (therapeutic device 4) according to an embodiment of the present invention. The therapeutic device 4 is a device used for treatment of arterial dissection or the like using the OSG method, for example, and in this example, as shown in FIG. ing. Although the details will be described later, the stent graft 2 is designed to be indwelled in a site to be treated (for example, in a blood vessel such as an artery) using the catheter 1 during the treatment described above.
(カテーテル1)
 カテーテル1は、患者における上記した治療対象の部位までステントグラフト2を運ぶ際に使用される医療機器である。このカテーテル1は、図1に示したように、デリバリシャフト11およびハンドル12(把持部,グリップ)を備えている。なお、デリバリシャフト11は、本発明における「シャフト」の一具体例に対応している。
(catheter 1)
A catheter 1 is a medical device used when carrying a stent graft 2 to the site to be treated in a patient. This catheter 1, as shown in FIG. 1, has a delivery shaft 11 and a handle 12 (grasping portion, grip). The delivery shaft 11 corresponds to a specific example of "shaft" in the present invention.
 デリバリシャフト11は、可撓性を有する管状構造(管状部材)からなり、自身の軸方向(長手方向)であるZ軸方向に沿って延在(延伸)する形状となっている。このデリバリシャフト11における軸方向に沿った先端領域では、上記した治療の際に、図1に示したように、後述するステントグラフト2が縮径された状態で、後述するカバー3の内部に保持されるようになっている。また、デリバリシャフト11における基端領域は、ハンドル12内に収容された部分に対応している。なお、このような先端領域と基端領域との間の中間領域は、図1に示したように、カバー3とハンドル12との間に位置する領域であり、外部に露出した領域となっている。 The delivery shaft 11 is made of a flexible tubular structure (tubular member), and has a shape that extends (stretches) along the Z-axis direction, which is its own axial direction (longitudinal direction). At the distal end region of the delivery shaft 11 along the axial direction, as shown in FIG. 1, the stent graft 2, which will be described later, is held inside the cover 3, which will be described later, with its diameter reduced, as shown in FIG. It has become so. Also, the base end region of the delivery shaft 11 corresponds to the portion accommodated within the handle 12 . The intermediate region between the distal end region and the proximal end region is a region located between the cover 3 and the handle 12 as shown in FIG. there is
 このようなデリバリシャフト11の軸方向に沿った長さ(全長)は、例えば300~900mm程度であり、好ましくは400~800mm程度、更に好ましくは450~750mm程度であり、好適な一例を示せば、670mmである。また、上記した先端領域の長さは、搭載されるステントグラフト2の長さに応じて適宜設定されるようになっており、例えば30~300mm程度であり、好ましくは50~270mm程度、更に好ましくは80~250mm程度である。上記した中間領域の長さは、例えば100~600mm程度であり、好ましくは150~550mm程度、更に好ましくは200~500mm程度であり、好適な一例を示せば、260mmである。 The length (total length) along the axial direction of the delivery shaft 11 is, for example, about 300 to 900 mm, preferably about 400 to 800 mm, more preferably about 450 to 750 mm. , 670 mm. In addition, the length of the tip region described above is appropriately set according to the length of the stent graft 2 to be mounted, and is, for example, about 30 to 300 mm, preferably about 50 to 270 mm, more preferably about 50 to 270 mm. It is about 80 to 250 mm. The length of the intermediate region is, for example, approximately 100 to 600 mm, preferably approximately 150 to 550 mm, more preferably approximately 200 to 500 mm, and a preferred example is 260 mm.
 また、上記した先端領域の外径は、例えば5~20mm程度であり、好ましくは8~15mm程度、好適な一例を示せば、11mmである。上記した中間領域の外径は、例えば5~20mm程度であり、好ましくは8~15mm程度、好適な一例を示せば、10mmである。 Further, the outer diameter of the tip region is, for example, about 5 to 20 mm, preferably about 8 to 15 mm, and a preferred example is 11 mm. The outer diameter of the intermediate region is, for example, approximately 5 to 20 mm, preferably approximately 8 to 15 mm, and a preferred example is 10 mm.
 ハンドル12は、図1に示したように、デリバリシャフト11の基端部分(基端領域)に装着されており、カテーテル1の使用時に操作者(医師)が掴む(握る)部分である。このハンドル12は、その軸方向(Z軸方向)に沿って延在する形状となっている。 As shown in FIG. 1, the handle 12 is attached to the proximal end portion (base end region) of the delivery shaft 11, and is the portion that the operator (doctor) grasps (grips) when using the catheter 1. The handle 12 has a shape extending along its axial direction (Z-axis direction).
 ハンドル12の軸方向に沿った長さは、例えば50~200mm程度であり、好ましくは60~180mm程度、更に好ましくは80~150mm程度であり、好適な一例を示せば、130mmである。また、ハンドル12の外径は、例えば3~30mm程度であり、好ましくは5~25mm程度、好適な一例を示せば、20mmである。なお、このようなハンドル12は、例えば、ポリカーボネート、アクリロニトリル-ブタジエン-スチレン共重合体(ABS)等の合成樹脂により構成されている。 The length of the handle 12 along the axial direction is, for example, about 50 to 200 mm, preferably about 60 to 180 mm, more preferably about 80 to 150 mm, and a preferred example is 130 mm. The outer diameter of the handle 12 is, for example, approximately 3 to 30 mm, preferably approximately 5 to 25 mm, and a preferred example is 20 mm. The handle 12 is made of synthetic resin such as polycarbonate or acrylonitrile-butadiene-styrene copolymer (ABS).
 ここで、図2は、図1に示したカバー3の内部の詳細構成例等を、模式的に側面図で表したものである。また、図3は、図1に示したステントグラフト2の詳細構成例を、模式的に表したものである。 Here, FIG. 2 is a side view schematically showing an example of the detailed configuration inside the cover 3 shown in FIG. FIG. 3 schematically shows a detailed configuration example of the stent graft 2 shown in FIG.
(ステントグラフト2)
 ステントグラフト2は、図1,図3に示したように、その軸方向(Z軸方向)に沿って延在する筒状(円筒状)構造を有しており、ステント21およびグラフト22を含んで構成されている。また、このステントグラフト2は、縮径状態で保持されることが可能な、自己拡張型の構造を有している。なお、ステントグラフト2の軸方向に沿った長さは、例えば150~270mm程度である。また、ステントグラフト2の拡張時の外径は、例えば17~39mm程度である。
(Stent graft 2)
The stent graft 2, as shown in FIGS. 1 and 3, has a tubular (cylindrical) structure extending along its axial direction (Z-axis direction), and includes a stent 21 and a graft 22. It is configured. Also, the stent graft 2 has a self-expanding structure that can be held in a reduced diameter state. The axial length of the stent graft 2 is, for example, about 150 to 270 mm. Further, the outer diameter of the stent graft 2 when expanded is, for example, about 17 to 39 mm.
 ステント21は、図1,図3に示したように、1または複数の線材W(素線)を用いて構成されており、この例では筒状(円筒状)構造を有している。具体的には、例えばこの筒状構造が網目状構造により構成されていると共に、このような筒状の網目状構造が、線材Wを所定のパターンで編み組むことにより形成されている。なお、この編み組みのパターンとしては、例えば、平織り、綾織り、メリヤス編み等が挙げられる。また、線材Wをジグザグ状に折り曲げて円筒状に加工したものを1つ以上配置することで、筒状の網目状構造を形成するようにしてもよい。 As shown in FIGS. 1 and 3, the stent 21 is configured using one or a plurality of wire rods W (element wires), and in this example has a tubular (cylindrical) structure. Specifically, for example, this tubular structure is configured by a mesh structure, and such a tubular mesh structure is formed by braiding the wire W in a predetermined pattern. The knitting pattern includes, for example, plain weave, twill weave, and knitting. Alternatively, a cylindrical network structure may be formed by arranging one or more cylindrically processed wire rods W that are bent in a zigzag shape.
 なお、線材Wの材料としては、金属線材が好ましく、特に熱処理による形状記憶効果や超弾性が付与される、形状記憶合金が好ましく採用される。ただし、用途によっては、線材Wの材料として、ステンレス、タンタル(Ta)、チタン(Ti)、白金(Pt)、金(Au)、タングステン(W)等を用いてもよい。上記した形状記憶合金としては、例えば、ニッケル(Ni)-Ti合金、銅(Cu)-亜鉛(Zn)-X(X=アルミニウム(Al),鉄(Fe)等)合金、Ni-Ti-X(X=Fe,Cu,バナジウム(V),コバルト(Co)等)合金などが好ましく使用される。なお、このような線材Wとして、例えば合成樹脂などを用いるようにしてもよい。また、金属線材の表面にAu,Ptなどをメッキ等の手段で被覆したもの、あるいは、Au,Ptなどの放射線不透過性の素材からなる芯材を合金で覆った複合的な線材を、線材Wとして用いるようにしてもよい。 As the material of the wire rod W, a metal wire rod is preferable, and in particular, a shape memory alloy, which is imparted with a shape memory effect and superelasticity by heat treatment, is preferably adopted. However, depending on the application, stainless steel, tantalum (Ta), titanium (Ti), platinum (Pt), gold (Au), tungsten (W), or the like may be used as the material of the wire W. Examples of the above-mentioned shape memory alloy include nickel (Ni)-Ti alloy, copper (Cu)-zinc (Zn)-X (X = aluminum (Al), iron (Fe), etc.) alloy, Ni-Ti-X (X=Fe, Cu, vanadium (V), cobalt (Co), etc.) alloys and the like are preferably used. As such a wire W, for example, a synthetic resin may be used. Also, a metal wire whose surface is coated with Au, Pt, etc. by means of plating, etc., or a composite wire, in which a core made of a radiopaque material such as Au, Pt, etc. is covered with an alloy, is used as a wire. W may be used.
 グラフト22は、図1,図3に示したように筒状(円筒状)の形状を有しており、ステント21の少なくとも一部分を覆う(被覆する)ように配置されている。具体的には、例えば、グラフト22がステント21(線材W)の内周側もしくは外周側を覆うように配置されていたり、あるいは、グラフト22がステント21(線材W)の外周側および内周側の双方を覆うように配置されている。 The graft 22 has a tubular (cylindrical) shape as shown in FIGS. 1 and 3 and is arranged to cover (cover) at least a portion of the stent 21 . Specifically, for example, the graft 22 is arranged so as to cover the inner peripheral side or the outer peripheral side of the stent 21 (wire W), or the graft 22 is arranged on the outer peripheral side and the inner peripheral side of the stent 21 (wire W). are arranged to cover both sides of the
 図3に示した例では、ステントグラフト2の軸方向(Z軸方向)に沿って、ステント配置領域A1およびステント非配置領域A2が設けられている。ステント配置領域A1は、ステントグラフト2における先端側に位置しており、ステント21がグラフト22に配置されている(ステント21およびグラフト22の双方が存在する)領域である。一方、ステント非配置領域A2は、ステントグラフト2における基端側(ステント配置領域A1の基端側)に位置しており、ステント21がグラフト22に配置されていない(グラフト22のみが存在する)領域である。なお、ステント配置領域A1の軸方向に沿った長さは、例えば130~250mm程度であり、ステント非配置領域A2の軸方向に沿った長さは、例えば20mm程度である。 In the example shown in FIG. 3, along the axial direction (Z-axis direction) of the stent graft 2, a stent-arranged area A1 and a stent-unarranged area A2 are provided. The stent arrangement area A1 is located on the distal end side of the stent graft 2 and is an area where the stent 21 is arranged on the graft 22 (both the stent 21 and the graft 22 are present). On the other hand, the non-stented region A2 is located on the proximal side of the stent graft 2 (the proximal side of the stented region A1), and is a region where the stent 21 is not placed on the graft 22 (only the graft 22 exists). is. The axial length of the stent-arranged region A1 is, for example, about 130 to 250 mm, and the axial length of the non-stent-arranged region A2 is, for example, about 20 mm.
 また、図1,図3に示した例では、ステントグラフト2の一部に、グラフト22およびステント21のうちの少なくともグラフト22が配置されていない、窓部20が設けられている。具体的には、この例では、ステント配置領域A1の一部に、グラフト22が配置されていない(ステント21がグラフト22から外部に露出している)、窓部20が設けられている。図3に示した例では、この窓部20は、ステントグラフト2の軸方向(Z軸方向)に沿った長軸を有する略矩形状となっている。なお、このような窓部20の長軸方向の長さは、例えば50~100mm程度であり、窓部20の短軸方向の長さ(ステントグラフト2の周方向に沿った幅)は、例えば、ステントグラフト2における外周長の30~50%程度の長さである。また、窓部20におけるステント非配置領域A2側の端部から、ステント配置領域A1とステント非配置領域A2との境界位置までの長さは、例えば20mm程度である。一方、窓部20におけるステント非配置領域A2側とは反対側の端部から、ステントグラフト2の端部までの長さは、例えば60~150mm程度である。 In addition, in the examples shown in FIGS. 1 and 3, a portion of the stent graft 2 is provided with a window 20 in which at least the graft 22 of the graft 22 and the stent 21 is not arranged. Specifically, in this example, a portion of the stent placement region A1 is provided with a window 20 in which the graft 22 is not placed (the stent 21 is exposed to the outside from the graft 22). In the example shown in FIG. 3, the window 20 has a substantially rectangular shape with a long axis along the axial direction (Z-axis direction) of the stent graft 2 . The length of the window portion 20 in the major axis direction is, for example, about 50 to 100 mm, and the length of the window portion 20 in the minor axis direction (the width along the circumferential direction of the stent graft 2) is, for example, The length is about 30 to 50% of the outer peripheral length of the stent graft 2 . The length from the end of the window 20 on the side of the non-stented region A2 to the boundary position between the non-stented region A1 and the non-stented region A2 is, for example, about 20 mm. On the other hand, the length from the end of the window 20 opposite to the non-stented region A2 to the end of the stent graft 2 is, for example, about 60 to 150 mm.
 グラフト22は、例えば縫着や接着、溶着等の手段によって、ステント21に連結されている。この場合、グラフト22は、ステント21の伸縮に影響を及ぼさないように、ステント21を被覆および連結するようになっている。なお、このようなグラフト22とステント21との連結部は、例えば、ステント21の両端部や中間部などに適宜設けられている。 The graft 22 is connected to the stent 21 by means of sewing, adhesion, welding, or the like. In this case, the graft 22 covers and connects the stent 21 so as not to affect the expansion and contraction of the stent 21 . Note that such connecting portions between the graft 22 and the stent 21 are appropriately provided, for example, at both end portions or an intermediate portion of the stent 21 .
 このようなグラフト22としては、例えば、熱可塑性樹脂を押出し成形やブロー成形などの成形方法で筒状に形成したもの、筒状に形成した熱可塑性樹脂の繊維や極細な金属線からなる編織物、筒状に形成した熱可塑性樹脂や極細な金属からなる不織布、筒状に形成した可撓性樹脂のシートや多孔質シート、溶剤に溶解された樹脂をエレクトロスピニング法によって肉薄の筒状に形成した構造体、などを用いることができる。 As such a graft 22, for example, a thermoplastic resin is formed into a tubular shape by a molding method such as extrusion molding or blow molding, or a knitted or woven fabric made of thermoplastic resin fibers or ultrafine metal wires formed into a tubular shape. , Cylindrical nonwoven fabrics made of thermoplastic resin or ultra-fine metal, Cylindrical flexible resin sheets or porous sheets, Solvent-dissolved resin formed into thin cylinders by electrospinning structure, etc. can be used.
 ここで、上記した編織物としては、平織、綾織などの公知の編物や織物を用いることができる。また、クリンプ加工などのヒダの付いたものを使用することもできる。なお、これらのうち、特に円筒状に形成した熱可塑性樹脂の繊維の編織物、更には筒状に形成した熱可塑性樹脂の繊維の平織りの織物が、強度や有孔度、生産性が優れるため、好ましいと言える。 Here, as the knitted fabric described above, known knitted fabrics and woven fabrics such as plain weave and twill weave can be used. In addition, it is also possible to use a material with pleats such as crimping. Among these, woven and woven fabrics of thermoplastic resin fibers formed in a cylindrical shape, and furthermore, plain weave fabrics of thermoplastic resin fibers formed in a cylindrical shape are excellent in strength, porosity, and productivity. can be said to be preferable.
 また、上記した熱可塑性樹脂としては、例えばポリエチレン、ポリプロピレン、エチレン-α-オレフィン共重合体などのポリオレフィン、ポリアミド、ポリウレタン、ポリエチレンテレフタレート、ポリブチレンテレフタレート、ポリシクロヘキサンテレフタレート、ポリエチレン-2,6-ナフタレートなどのポリエステル、ポリフッ化エチレンやポリフッ化プロピレンなどのフッ素樹脂等、耐久性および組織反応の少ない樹脂などを用いることができる。なお、これらのうち、特に、化学的に安定で耐久性が大きく、かつ組織反応の少ない、ポリエチレンテレフタレートなどのポリエステル、ポリフッ化エチレンやポリフッ化プロピレンなどのフッ素樹脂を好ましく用いることができる。 Examples of the above thermoplastic resins include polyolefins such as polyethylene, polypropylene, and ethylene-α-olefin copolymers, polyamides, polyurethanes, polyethylene terephthalate, polybutylene terephthalate, polycyclohexane terephthalate, polyethylene-2,6-naphthalate, and the like. polyester, fluororesin such as polyethylene fluoride and polypropylene fluoride, and other resins with less durability and tissue reaction can be used. Of these, polyesters such as polyethylene terephthalate, and fluororesins such as polyethylene fluoride and polypropylene fluoride, which are chemically stable, highly durable, and less prone to tissue reaction, can be preferably used.
(カバー3)
 カバー3は、前述したように、デリバリシャフト11の先端領域において、ステントグラフト2を縮径状態で保持するための部材である。具体的には、この例では図1~図3に示したように、前述したステント配置領域A1がデリバリシャフト11の先端側に位置すると共に前述したステント非配置領域A2がデリバリシャフト11の基端側に位置する向きで、ステントグラフト2がカバー3内に保持されるようになっている。なお、このカバー3の外径は、例えば5.0~20.0mm程度であり、好ましくは7.5~18.0mm程度、好適な一例を示せば、13.0mmである。
(Cover 3)
As described above, the cover 3 is a member for holding the stent graft 2 in a diameter-reduced state in the distal region of the delivery shaft 11 . Specifically, in this example, as shown in Figs. In a sideways orientation the stent graft 2 is adapted to be retained within the cover 3 . The outer diameter of the cover 3 is, for example, approximately 5.0 to 20.0 mm, preferably approximately 7.5 to 18.0 mm, and a preferred example is 13.0 mm.
 このようなカバー3は、この例では軟質カバーにより構成されている。縮径状態のステントグラフト2を軟質カバーで覆うことにより、このステントグラフト2を確実に保持することができるようになっている。また、カバー3が軟質であることにより、硬質の筒状体(シース)などと比較して、デリバリシャフト11における先端領域の形状変化に、カバー3が容易に追従することが可能となっている。 Such a cover 3 is composed of a soft cover in this example. By covering the stent graft 2 in a diameter-reduced state with a soft cover, the stent graft 2 can be reliably held. Further, since the cover 3 is soft, it is possible for the cover 3 to easily follow changes in the shape of the distal end region of the delivery shaft 11 compared to a hard tubular body (sheath) or the like. .
 ここで、図1,図2に示したように、本実施の形態のカバー3は、デリバリシャフト11の軸方向(Z軸方向)に沿って互いに分離配置された、2種類のカバー(カバー31,32)によって構成されている。カバー31は、軸方向に沿ってカバー32の基端側に配置されており、カバー32は、軸方向に沿ってカバー31の先端側に配置されている。 Here, as shown in FIGS. 1 and 2, the cover 3 of the present embodiment includes two types of covers (covers 31 , 32). The cover 31 is arranged on the base end side of the cover 32 along the axial direction, and the cover 32 is arranged on the distal end side of the cover 31 along the axial direction.
 なお、カバー31は、本発明における「第1のカバー」の一具体例に対応している。また、カバー32は、本発明における「第2のカバー」の一具体例に対応している。 Note that the cover 31 corresponds to a specific example of the "first cover" in the present invention. Also, the cover 32 corresponds to a specific example of the "second cover" in the present invention.
 カバー31は、図1,図2に示したように、軸方向に沿って延在する筒状構造となっている。このカバー31の軸方向に沿った長さは、例えば30~150mm程度である。 As shown in FIGS. 1 and 2, the cover 31 has a cylindrical structure extending along the axial direction. The axial length of the cover 31 is, for example, about 30 to 150 mm.
 カバー32は、図1,図2に示したように、内層部321および外層部322を有する2層構造(2重構造)を有している。つまり、カバー32は、筒状の外層部322と、この外層部322の内周側に位置する内層部321とを有している。図2に示した例では、外層部322は、デリバリシャフト11の外周側に位置しており、内層部321は、デリバリシャフト11の内周側に位置している。また、このカバー32には、これらの外層部322と内層部321とをデリバリシャフト11の先端側にて繋ぐ(連結する)部分である、折り返し部323が設けられている(図1,図2参照)。具体的には、このカバー32は、筒状のチューブ部材を内側に折り返すことによって形成されており、折り返された部分が内層部321に対応している。また、このような内層部321の基端側は、図1,図2に示したように、デリバリシャフト11内を介して、カテーテル1の基端側まで延在している。具体的には図1に示したように、内層部321の基端側は、デリバリシャフト11およびハンドル12の内部をそれぞれ挿通し、ハンドル12の基端側から突出するようになっている。 The cover 32 has a two-layer structure (double structure) having an inner layer portion 321 and an outer layer portion 322, as shown in FIGS. In other words, the cover 32 has a tubular outer layer portion 322 and an inner layer portion 321 located on the inner peripheral side of the outer layer portion 322 . In the example shown in FIG. 2 , the outer layer portion 322 is positioned on the outer peripheral side of the delivery shaft 11 and the inner layer portion 321 is positioned on the inner peripheral side of the delivery shaft 11 . Further, the cover 32 is provided with a folded portion 323 which is a portion that connects (connects) the outer layer portion 322 and the inner layer portion 321 at the distal end side of the delivery shaft 11 (see FIGS. 1 and 2). reference). Specifically, the cover 32 is formed by folding a cylindrical tube member inward, and the folded portion corresponds to the inner layer portion 321 . 1 and 2, the proximal side of the inner layer portion 321 extends to the proximal side of the catheter 1 through the inside of the delivery shaft 11. As shown in FIGS. Specifically, as shown in FIG. 1 , the proximal side of the inner layer portion 321 is inserted through the insides of the delivery shaft 11 and the handle 12 , respectively, and protrudes from the proximal side of the handle 12 .
 また、図2に示したように、カバー31とデリバリシャフト11との間(層間)、および、カバー32における外層部322とデリバリシャフト11との間にそれぞれ、ステントグラフト2が前述した縮径状態で、保持されるようになっている(矢印P0参照)。そして、図1,図2に示した例では、このような縮径状態のステントグラフト2において、前述した窓部20の先端が、カバー31,32同士の境界Pb付近に位置するようになっている。換言すると、ステントグラフト2における窓部20の先端が、カバー31,32同士の境界Pb付近に位置することとなるように、これらのカバー31,32内において、ステントグラフト2が縮径状態で保持されるようになっている。 Further, as shown in FIG. 2, the stent graft 2 is placed between the cover 31 and the delivery shaft 11 (between the layers) and between the outer layer portion 322 of the cover 32 and the delivery shaft 11 in the diameter-reduced state described above. , is held (see arrow P0). In the example shown in FIGS. 1 and 2, in the stent graft 2 in such a diameter-reduced state, the tip of the window 20 is positioned near the boundary Pb between the covers 31 and 32. . In other words, the stent graft 2 is held in a diameter-reduced state within these covers 31 and 32 so that the tip of the window 20 in the stent graft 2 is positioned near the boundary Pb between the covers 31 and 32. It's like
 なお、このようなカバー31およびカバー32(外層部322、内層部321および折り返し部323など)はそれぞれ、例えば、半透明性または透明性(光透過性)を示す材料を用いて構成されている。そのような半透明性または透明性を示す材料としては、例えば、ポリエチレン、ポリプロピレン、エチレン-α-オレフィン共重合体などのポリオレフィン、ポリアミド、ポリイミド、ポリウレタン、ポリエチレンテレフタレート、ポリブチレンテレフタレート、ポリシクロヘキサンテレフタレート、ポリエチレン-2,6-ナフタレートなどのポリエステル、ポリフッ化エチレンやポリフッ化プロピレンなどのフッ素樹脂等、シリコーン等の樹脂の繊維からなる織物または編み物、もしくはフィルムやシート等の構造体、あるいはそれらを組み合わせたものなどが挙げられる。なお、これらにおける補強等を目的として、金属等の細線や短繊維が含まれていてもよい。ちなみに、前述したカバー3(カバー31,32)を構成する部材としては、上記の材料を用いてあらかじめ筒状として製造されたもの、または平坦状のものを筒状に加工したもの、あるいはそれらの組み合わせからなるもの等が挙げられる。 The cover 31 and the cover 32 (the outer layer portion 322, the inner layer portion 321, the folded portion 323, etc.) are each made of, for example, a material exhibiting translucency or transparency (optical transparency). . Examples of such translucent or transparent materials include polyolefins such as polyethylene, polypropylene, and ethylene-α-olefin copolymers, polyamides, polyimides, polyurethanes, polyethylene terephthalate, polybutylene terephthalate, polycyclohexane terephthalate, Polyester such as polyethylene-2,6-naphthalate, fluorine resin such as polyethylene fluoride and polypropylene fluoride, woven fabric or knitted fabric made of fibers of resin such as silicone, or structure such as film or sheet, or a combination thereof things, etc. For the purpose of reinforcement or the like in these, thin wires or short fibers such as metal may be included. Incidentally, the members constituting the cover 3 (covers 31 and 32) described above may be those which are manufactured in advance into a tubular shape using the above-mentioned materials, or those which are flattened into a tubular shape, or those which are formed into a tubular shape. The thing which consists of a combination, etc. are mentioned.
 このようなカバー3(カバー31,32)の構成により、後述するカバー31,32に対する引っ張り操作によって、ステントグラフト2を拡張させる際の動作が行われるようになっている。なお、このようなステントグラフト2を拡張させる際の動作(治療の際のステントグラフト2の留置方法)の詳細については、後述する(図6)。 With such a configuration of the cover 3 (covers 31 and 32), the stent graft 2 is expanded by pulling the covers 31 and 32, which will be described later. The details of the operation for expanding the stent graft 2 (the method of placing the stent graft 2 during treatment) will be described later (FIG. 6).
[動作および作用・効果]
(A.基本動作)
 本実施の形態の治療装置4は、例えば動脈解離等の治療の際に用いられる。具体的には、操作者がカテーテル1を操作することで、患者における治療対象の部位(例えば動脈等の血管内)まで縮径された状態のステントグラフト2が運ばれ、拡張された後に留置される。このようにして治療対象の部位にステントグラフト2が留置されることで、血管内壁の裂け目への血流を抑えつつ、血管管腔を拡張および保持することが可能となる。また、特にこのステントグラフト2は、例えば、胸部大動脈における動脈解離等の治療方法の1つである、OSG法を利用した治療の際に用いられる。
[Operation and action/effect]
(A. Basic operation)
The treatment device 4 of the present embodiment is used, for example, for treatment of arterial dissection and the like. Specifically, the operator manipulates the catheter 1 to carry the stent graft 2 in a reduced diameter state to a site to be treated (for example, inside a blood vessel such as an artery) in a patient, and then indwell it after being expanded. . By indwelling the stent graft 2 at the site to be treated in this manner, it is possible to expand and maintain the vascular lumen while suppressing blood flow to the cleft of the inner wall of the blood vessel. In particular, the stent graft 2 is used, for example, in treatment using the OSG method, which is one of treatment methods such as arterial dissection in the thoracic aorta.
 ここで、図4を参照して、このOSG法を利用した動脈解離(動脈瘤)等の治療方法(治療装置4の使用方法)の概要について説明する。 Here, with reference to FIG. 4, an outline of a treatment method for arterial dissection (aneurysm) using this OSG method (a method of using the treatment device 4) will be described.
 図4は、そのような治療時における治療装置4の使用方法の一例を、模式図で表したものである。なお、ここでは、治療対象の血管である動脈9(胸部大動脈)が、遠位弓部大動脈(図4中に示した弓部分岐9Bの部分)および近位下行大動脈を含む部分である場合を、例に挙げて説明する。 FIG. 4 is a schematic diagram showing an example of how to use the treatment device 4 during such treatment. Here, it is assumed that the artery 9 (thoracic aorta), which is the blood vessel to be treated, includes the distal arch aorta (the portion of the arch bifurcation 9B shown in FIG. 4) and the proximal descending aorta. , will be described as an example.
 まず、例えば図4に示したように、このOSG法では、患者の開胸後に、図1~図3に示した構成の治療装置4を使用して、動脈9の一部を切開してなる開口から、縮径された状態のステントグラフト2を挿入させる(矢印P8参照)。具体的には、カテーテル1におけるデリバリシャフト11の先端側(カバー3側)から、ステントグラフト2が挿入される。このとき、例えば図1,図2に示したように、カテーテル1におけるデリバリシャフト11の先端領域には、ステントグラフト2が縮径された状態で、カバー3の内部に保持されている。 First, as shown in FIG. 4, for example, in this OSG method, after the patient's chest is opened, a portion of the artery 9 is incised using the therapeutic device 4 configured as shown in FIGS. The stent graft 2 in a reduced diameter state is inserted through the opening (see arrow P8). Specifically, the stent graft 2 is inserted from the distal end side (cover 3 side) of the delivery shaft 11 in the catheter 1 . At this time, for example, as shown in FIGS. 1 and 2, the stent graft 2 is held inside the cover 3 at the distal end region of the delivery shaft 11 of the catheter 1 in a reduced diameter state.
 ここで、治療対象の動脈9が例えば動脈解離状態である場合、例えば図4に示したように、その動脈9内には、本来の血流路である動脈内腔(真腔9T)と、血管内壁が裂けることによって生じた新たな内腔(偽腔9F)とが存在することになる。このような場合、カテーテル1が偽腔9F内に誤挿入されるおそれを回避するため、カテーテル1を所定のガイドワイヤに沿わせて挿入する。つまり、カテーテル1における細孔(ルーメン)内に、そのようなガイドワイヤを挿通させながら、カテーテル1を挿入する。 Here, when the artery 9 to be treated is in an arterial dissection state, for example, as shown in FIG. A new lumen (false lumen 9F) is present as a result of tearing of the inner wall of the blood vessel. In such a case, the catheter 1 is inserted along a predetermined guide wire in order to avoid the risk of the catheter 1 being erroneously inserted into the false lumen 9F. That is, the catheter 1 is inserted while inserting such a guide wire into the lumen of the catheter 1 .
 具体的には、まず、患者の足の付け根(鼠蹊部)から動脈9内へガイドワイヤを挿入させ、この動脈9内を通って上記した開口から、外部へと引き出すようにする。ここで、このガイドワイヤは末梢側から動脈9内へ挿入されることから、このガイドワイヤは誤って偽腔9F内に挿入されることなく、確実に真腔9T内へと挿入される。なお、このようなガイドワイヤの長さは、例えば約50~450cm程度であり、その外径は、例えば約0.2~1.0mm程度である。 Specifically, first, a guide wire is inserted into the artery 9 from the patient's groin (groin), passed through the artery 9, and pulled out from the opening described above. Since the guidewire is inserted into the artery 9 from the peripheral side, the guidewire is reliably inserted into the true lumen 9T without being mistakenly inserted into the false lumen 9F. The length of such a guide wire is, for example, approximately 50 to 450 cm, and its outer diameter is, for example, approximately 0.2 to 1.0 mm.
 続いて、上記した開口を入口としてガイドワイヤに沿わせるように、カテーテル1を動脈9内に挿入させる(矢印P8参照)。前述したように、ガイドワイヤは確実に真腔9T内へ挿入されていることから、このガイドワイヤに沿わせるようにしてカテーテル1を動脈9内へ挿入させることで、このカテーテル1もまた、確実に真腔9T内へ挿入されることになる。すなわち、動脈解離状態の場合であっても、カテーテル1が偽腔9Fに挿入されてしまうおそれが回避される。 Subsequently, the catheter 1 is inserted into the artery 9 along the guide wire using the opening as an entrance (see arrow P8). As described above, since the guide wire is surely inserted into the true lumen 9T, by inserting the catheter 1 into the artery 9 along the guide wire, the catheter 1 can also be reliably inserted. is inserted into the true lumen 9T. That is, even in the case of arterial dissection, the risk of the catheter 1 being inserted into the false lumen 9F is avoided.
 次いで、例えば図4に示したように、この治療装置4を使用して、動脈9における治療対象の部位(動脈瘤の形成箇所付近)を超えた部位まで、ステントグラフト2を到達させる(矢印P8参照)。 Next, as shown in FIG. 4, for example, the treatment device 4 is used to allow the stent graft 2 to reach a site in the artery 9 beyond the site to be treated (near the aneurysm formation site) (see arrow P8). ).
 続いて、ステント21の自己拡張力を利用することで、このステントグラフト2を拡径(展開)させる動作がなされる。具体的には、まず、カテーテル1の操作者によって、後述するカバー31,32に対する引っ張り操作(基端側へと引っ張る操作)が、行われる。すると、詳細は後述するが、これらのカバー31,32がそれぞれ、ステントグラフト2から取り去られる。その結果、このステントグラフト2が、ステント21の自己拡張力によって、次第に拡張する。 Subsequently, by using the self-expanding force of the stent 21, the diameter of the stent graft 2 is expanded (deployed). Specifically, first, the operator of the catheter 1 performs a pulling operation (an operation of pulling toward the proximal end) with respect to the covers 31 and 32, which will be described later. Then, the covers 31 and 32 are removed from the stent graft 2, details of which will be described later. As a result, this stent graft 2 gradually expands due to the self-expanding force of the stent 21 .
 これにより、例えば図4に示したように、ステントグラフト2が動脈9の内壁に固定される。その結果、動脈瘤の形成箇所付近における動脈9の管腔が、拡張および保持されることになる。その後、このステントグラフト2の基端側(ステント非配置領域A2におけるグラフト22)と動脈9(患者の血管)とを縫合することで、吻合する。なお、例えば図4に示したように、更に必要に応じて、このステントグラフト2とは別の人工血管90を、この吻合部分と吻合するようにしてもよい。 Thereby, the stent graft 2 is fixed to the inner wall of the artery 9 as shown in FIG. 4, for example. As a result, the lumen of artery 9 near the site of aneurysm formation is dilated and retained. Thereafter, the proximal end side of the stent graft 2 (the graft 22 in the non-stented region A2) and the artery 9 (vessel of the patient) are sutured to form an anastomosis. Further, as shown in FIG. 4, for example, an artificial blood vessel 90 other than the stent graft 2 may be anastomosed with the anastomosis portion, if necessary.
 このようにして、動脈瘤の内周がステントグラフト2によって覆われることで、血流はステントグラフト2内を通るようになり(図4中の矢印P91参照)、血管内壁の裂け目(偽腔9F)への血液の流入が遮断される結果、動脈瘤に血圧等が作用しなくなる。したがって、動脈瘤における瘤径の拡大および血管の破裂を、予防することができる。 In this way, the inner periphery of the aneurysm is covered with the stent graft 2, allowing blood flow to pass through the stent graft 2 (see arrow P91 in FIG. 4) and flow into the cleft in the inner wall of the blood vessel (false lumen 9F). As a result of blocking the inflow of blood to the aneurysm, blood pressure and the like cease to act on the aneurysm. Therefore, enlargement of the aneurysm diameter and rupture of the blood vessel can be prevented.
 また、特にこのOSG法を利用した治療方法では、患者の足の付け根(鼠蹊部)からカテーテルを挿入してステントグラフトを治療対象部位まで運ぶ治療方法(従来の治療方法)と比較して、以下の利点が得られる。すなわち、この従来の治療方法では処置が極めて困難な、重要な分枝が存在する部位(例えば弓部大動脈)の処置ができる、という利点が得られる。また、病変部位を切除して人工血管によって置換すると共にその両端を吻合する方法と比較すると、下行大動脈縫合(末梢側吻合)が、ステントグラフト2による固定によって代用されることになる。つまり、このOSG法では、ステントグラフト2の先端側と下行大動脈との間の吻合が省略されることから、吻合作業が簡略化される。したがって、手術時間(体外循環時間)を短縮化することができると共に、更に下行大動脈の縫合に必要な左開胸または大きな胸部切開が回避されるため、患者への手術侵襲が軽減される(治療の際の患者への負担が軽減される)。更に、このOSG法では、人工血管の移植範囲を広範囲に設定でき、付近の合併症の外科処置も可能となるという利点もある。加えて、OSG法に適用するステントグラフトは、上記した従来の治療方法のように鼠蹊部から導入するわけではないため、細い血管を通過させる必要がなく、縮径させた状態でもある程度なら外径が大きくても(太くても)よいことになる。 In particular, in the treatment method using this OSG method, compared with the treatment method (conventional treatment method) in which a catheter is inserted from the patient's groin (groin) to carry the stent graft to the treatment target site, the following points are observed. You get the advantage. That is, there is the advantage of being able to treat sites with important branches (eg, the aortic arch) that are extremely difficult to treat with this conventional treatment method. In addition, compared with the method of resecting the lesion site, replacing it with an artificial blood vessel, and anastomosing both ends of the anastomosis, the descending aorta suture (peripheral anastomosis) is replaced by fixation with the stent graft 2 . In other words, the OSG method omits the anastomosis between the distal end of the stent graft 2 and the descending aorta, thereby simplifying the anastomosis. Therefore, the operation time (extracorporeal circulation time) can be shortened, and the left thoracotomy or large chest incision required for suturing the descending aorta can be avoided, thereby reducing the surgical invasiveness to the patient (treatment reduce the burden on the patient when Furthermore, this OSG method has the advantage that the grafting range of the artificial blood vessel can be set in a wide range, and surgical treatment of nearby complications is also possible. In addition, since the stent graft applied to the OSG method is not introduced from the groin as in the above-described conventional treatment method, there is no need to pass through a thin blood vessel, and the outer diameter can be reduced to some extent even when the diameter is reduced. Even if it is big (thick), it is good.
 更に、詳細は後述するが、本実施の形態では例えば図4に示したように、ステントグラフト2が留置される血管(動脈9等)からの分岐部分(弓部分岐9B)に対しても、前述した窓部20内のステント21の隙間から、血液が流れるようになる(矢印P92参照)。したがって、この分岐部分の再建処置(人工血管との吻合処置等)が不要となるため、治療の際の手術時間の短縮化や、侵襲の低減を図ることが可能となる。 Furthermore, although the details will be described later, in this embodiment, as shown in FIG. Blood flows through the gaps between the stents 21 in the windows 20 (see arrow P92). Therefore, reconstruction treatment (anastomosis with an artificial blood vessel, etc.) for this bifurcated portion becomes unnecessary, so that it is possible to shorten the operation time and reduce invasiveness during treatment.
(B.カバー3における作用・効果)
 続いて、図1~図4に加えて図5,図6を参照して、本実施の形態のカバー3(カバー31,32)における作用および効果について、比較例と比較しつつ詳細に説明する。
(B. Functions and effects of cover 3)
Next, with reference to FIGS. 5 and 6 in addition to FIGS. 1 to 4, the action and effect of the cover 3 (covers 31 and 32) of the present embodiment will be described in detail while comparing with a comparative example. .
 図5は、比較例に係る治療装置(治療装置104)を用いた場合における、ステントグラフト2の留置方法の一例を、模式的に表したものである。また、図6は、本実施の形態の治療装置4を用いた場合における、ステントグラフト2の留置方法の一例を、模式的に表したものである。なお、これらの図5,図6中にはそれぞれ、図4を用いて前述した、カテーテル1の動脈9内への挿入方向(矢印P8)を、併せて示している。 FIG. 5 schematically shows an example of a placement method of the stent graft 2 when using a therapeutic device (therapeutic device 104) according to a comparative example. Moreover, FIG. 6 schematically shows an example of a placement method of the stent graft 2 in the case of using the therapeutic device 4 of the present embodiment. 5 and 6 also show the insertion direction (arrow P8) of the catheter 1 into the artery 9 described above with reference to FIG.
(B-1.比較例の留置方法)
 最初に、図5に示した比較例の治療装置104では、以下のようにして、治療対象の血管(動脈9)に対する、ステントグラフト2の留置が行われる。なお、この比較例の治療装置104では、実施の形態の治療装置4において、前述した2種類のカバー31,32から構成されるカバー3の代わりに、単一構成のカバー103を設けるようにしたものとなっている。
(B-1. Placement method of comparative example)
First, in the therapeutic device 104 of the comparative example shown in FIG. 5, the stent graft 2 is placed in the blood vessel (artery 9) to be treated as follows. In the treatment apparatus 104 of this comparative example, instead of the cover 3 composed of the two types of covers 31 and 32 in the treatment apparatus 4 of the embodiment, a single cover 103 is provided. It is a thing.
 この比較例では、まず、例えば図5(A)に示したように、カテーテル1の操作者によって、カバー103における基端部が、デリバリシャフト11の基端方向へと引っ張られる(矢印P101参照)。このようなカバー103に対する引っ張り操作が行われることで、例えば図5(B),図5(C)に示したように、縮径状態のステントグラフト2が、ステント21の自己拡張力により、カバー103内から順次展開されて、拡径していく(矢印P102参照)。具体的には、ステントグラフト2は、その先端側から基端側へ向けて徐々に展開され、拡径していく。その結果、例えば図5(C)に示したように、最終的には、ステントグラフト2全体が展開され、拡径することになる。 In this comparative example, first, as shown in FIG. 5A, for example, the operator of the catheter 1 pulls the proximal end of the cover 103 toward the proximal end of the delivery shaft 11 (see arrow P101). . By performing such a pulling operation on the cover 103, the stent graft 2 in a diameter-reduced state is pulled by the self-expanding force of the stent 21, as shown in FIGS. It expands sequentially from the inside and expands in diameter (see arrow P102). Specifically, the stent graft 2 is gradually deployed from the distal end side to the proximal end side to expand its diameter. As a result, as shown in FIG. 5(C), the entire stent graft 2 is finally deployed and expanded in diameter.
 ところが、このようなカバー103を備えた治療装置104を使用する比較例では、上記した引っ張り操作によって、縮径状態のステントグラフト2がカバー103内から展開されて拡径する際に、以下のような問題が生じ得る。すなわち、ステントグラフト2が拡径する際に、ステントグラフト2がその軸方向(Z軸方向)に沿っても伸びることに起因して、ステントグラフト2の留置位置のずれ(軸方向への位置ずれ)が、生じ得る(図5(C)中に示した矢印m参照)。そして、そのようなステントグラフト2の留置位置のずれが大きくなると、OSG法を利用した動脈解離等の治療の際に、利便性が損なわれてしまうおそれがある。 However, in the comparative example using the therapeutic device 104 having such a cover 103, when the diameter-reduced stent graft 2 is deployed from within the cover 103 and expanded in diameter by the pulling operation described above, the following problems occur. Problems can arise. That is, when the diameter of the stent graft 2 expands, the stent graft 2 also extends along its axial direction (Z-axis direction). (See arrow m shown in FIG. 5(C)). Further, if such deviation of the indwelling position of the stent graft 2 becomes large, there is a possibility that the convenience will be impaired in the treatment of arterial dissection or the like using the OSG method.
(B-2.本実施の形態の留置方法)
 これに対して、図6に示した本実施の形態の治療装置4では、前述した2種類のカバー31,32を利用して、以下のようにして、治療対象の血管(動脈9)に対する、ステントグラフト2の留置が行われる。
(B-2. Placement method according to the present embodiment)
On the other hand, in the treatment apparatus 4 of the present embodiment shown in FIG. 6, the above-described two types of covers 31 and 32 are used to perform Placement of the stent graft 2 is performed.
 すなわち、まず、例えば図6(A)に示したように、カテーテル1の操作者によって、カバー32の内層部321における基端側を、カテーテル1の基端方向へと引っ張る操作(第2の引っ張り操作)が、行われる(矢印P12参照)。このようなカバー32の内層部321に対する引っ張り操作が行われることで、カバー32の外層部322が、折り返し部323を介してデリバリシャフト11の内部へと引き込まれ(矢印P120参照)、カテーテル1の基端側へと徐々に引っ張られることになる。 First, as shown in FIG. 6A, for example, the operator of the catheter 1 pulls the proximal side of the inner layer 321 of the cover 32 toward the proximal direction of the catheter 1 (second pulling). operation) is performed (see arrow P12). By performing such a pulling operation on the inner layer portion 321 of the cover 32, the outer layer portion 322 of the cover 32 is pulled into the delivery shaft 11 via the folded portion 323 (see arrow P120), and the catheter 1 is pulled. It will be gradually pulled proximally.
 したがって、例えば図6(B)に示したように、縮径状態のステントグラフト2が、ステント21の自己拡張力により、カバー32内から順次展開されて、拡径していく(矢印P2参照)。具体的には、ステントグラフト2は、その先端側から基端側(この例では、カバー31,32同士の境界Pb付近)へ向けて、徐々に展開され、拡径していく。 Therefore, for example, as shown in FIG. 6(B), the stent graft 2 in a diameter-reduced state is sequentially expanded from within the cover 32 by the self-expanding force of the stent 21 and expands in diameter (see arrow P2). Specifically, the stent graft 2 is gradually deployed from the distal end side to the proximal end side (near the boundary Pb between the covers 31 and 32 in this example) and expands in diameter.
 続いて、例えば図6(B)に示したように、カテーテル1の操作者によって、カバー31における基端側を、デリバリシャフト11の基端方向へと引っ張る操作(第1の引っ張り操作)が、行われる(矢印P11参照)。つまり、図6に示した例では、上記したカバー32に対する引っ張り操作(第2の引っ張り操作)が開始された後に、カバー31に対する引っ張り操作(第1の引っ張り操作)が開始されている。 Subsequently, as shown in FIG. 6B, for example, the operator of the catheter 1 pulls the proximal side of the cover 31 toward the proximal end of the delivery shaft 11 (first pulling operation). (see arrow P11). That is, in the example shown in FIG. 6, the pulling operation (first pulling operation) for the cover 31 is started after the above-described pulling operation (second pulling operation) for the cover 32 is started.
 このようなカバー31に対する引っ張り操作も行われることで、例えば図6(C),図6(D)に示したように、ステントグラフト2における縮径状態の部分が、ステント21の自己拡張力により、カバー31内からも順次展開されて、拡径していく(矢印P2参照)。具体的には、この例では、ステントグラフト2における基端側(上記した境界Pbよりも基端側)の部分が、その先端側から基端側へ向けて徐々に展開され、拡径していく。 By also performing such a pulling operation on the cover 31, as shown in FIGS. They are also successively expanded from inside the cover 31 to expand in diameter (see arrow P2). Specifically, in this example, the portion of the stent graft 2 on the proximal side (the proximal side of the boundary Pb described above) is gradually deployed from the distal side toward the proximal side and expands in diameter. .
 その結果、例えば図6(D)に示したように、最終的には、ステントグラフト2全体(窓部20を含む全領域)が展開され、拡径することになる。 As a result, for example, as shown in FIG. 6(D), the entire stent graft 2 (the entire area including the window 20) is finally deployed and expanded in diameter.
(B-3.作用・効果)
 このようにして本実施の形態の治療装置4では、デリバリシャフト11の先端領域においてステントグラフト2を縮径状態にて保持するためのカバー3が、2種類のカバー(基端側のカバー31および先端側のカバー32)に、軸方向に沿って分離配置されている。そして、カバー31とデリバリシャフト11との間、および、カバー32における外層部322とデリバリシャフト11との間にそれぞれ、ステントグラフト2が縮径状態で保持されている。
(B-3. Action and effect)
Thus, in the therapeutic device 4 of the present embodiment, the cover 3 for holding the stent graft 2 in a diameter-reduced state in the distal end region of the delivery shaft 11 includes two types of covers (the proximal cover 31 and the distal end cover 31). It is axially separated on the side cover 32). The stent graft 2 is held in a diameter-reduced state between the cover 31 and the delivery shaft 11 and between the outer layer portion 322 of the cover 32 and the delivery shaft 11 .
 これにより本実施の形態では、例えば、動脈9等における患部に対してステントグラフト2を留置する治療の際に、以下のようになる。すなわち、そのような治療の際に、カバー31における基端側をデリバリシャフト11の基端方向へと引っ張ると共に、カバー32の内層部321における基端側をカテーテル1の基端方向へと引っ張る操作(引っ張り操作)によって、縮径状態のステントグラフト2がカバー31,32内から展開されて拡径する際に、以下のようになる。つまり、これらのカバー31,32同士の境界Pb付近(ステントグラフト2における中間位置付近)へ向けて、軸方向に沿ってステントグラフトが引っ張られることになる。その結果、拡径されたステントグラフト2が患者体内に留置される際に、本実施の形態では上記比較例とは異なり、ステントグラフト2の留置位置のずれ(軸方向への位置ずれ)が、抑制される。よって、本実施の形態では、そのような2種類のカバー31,32を備えた治療装置4を用いて治療を行うことで、上記した治療の際の利便性を、向上させることが可能となる。 As a result, in this embodiment, for example, when the stent graft 2 is placed in the affected area of the artery 9 or the like, the treatment is as follows. That is, during such treatment, an operation of pulling the proximal side of the cover 31 toward the proximal direction of the delivery shaft 11 and pulling the proximal side of the inner layer portion 321 of the cover 32 toward the proximal direction of the catheter 1 is performed. When the diameter-reduced stent graft 2 is expanded from the covers 31 and 32 by (pulling operation), the following occurs. That is, the stent graft is pulled along the axial direction toward the vicinity of the boundary Pb between the covers 31 and 32 (near the intermediate position of the stent graft 2). As a result, when the diameter-expanded stent graft 2 is left in the patient's body, in the present embodiment, unlike the comparative example, displacement of the stent graft 2 (positional displacement in the axial direction) is suppressed. be. Therefore, in the present embodiment, by performing treatment using the treatment apparatus 4 having such two types of covers 31 and 32, it is possible to improve the convenience of the treatment described above. .
 また、本実施の形態では、上記したカバー31に対する引っ張り操作(第1の引っ張り操作)と、上記したカバー32の内層部321に対する引っ張り操作(第2の引っ張り操作)とがそれぞれ行われることで、縮径状態のステントグラフト2が、カバー31,32内からそれぞれ展開されて、拡径するようになっている。このようにして、上記した引っ張り操作としての上記第1および第2の引っ張り操作がそれぞれ行われることで、縮径状態のステントグラフト2がカバー31,32内から展開されて拡径する際に、上記したようにして、ステントグラフト2の留置位置のずれを抑制することが可能となる。 Further, in the present embodiment, by performing the above-described pulling operation (first pulling operation) on the cover 31 and the above-described pulling operation (second pulling operation) on the inner layer portion 321 of the cover 32, The diameter-reduced stent graft 2 is expanded from the covers 31 and 32 to expand its diameter. By performing the first and second pulling operations as the pulling operations in this way, when the diameter-reduced stent graft 2 is deployed from the covers 31 and 32 and expanded in diameter, the above-mentioned In this way, it is possible to suppress the displacement of the indwelling position of the stent graft 2 .
 更に、本実施の形態では、上記した第2の引っ張り操作が開始された後に上記した第1の引っ張り操作が開始されることで、縮径状態のステントグラフト2が、カバー31,32内からそれぞれ、この順序にて展開され、拡径されるようになっている。これにより、上記したステントグラフト2の留置位置のずれが、更に抑制され易くなる結果、治療の際の利便性を、更に向上させることが可能となる。 Furthermore, in the present embodiment, the above-described first pulling operation is started after the above-described second pulling operation is started, so that the diameter-reduced stent graft 2 is pulled from inside the covers 31 and 32, respectively. They are deployed and expanded in this order. As a result, the displacement of the indwelling position of the stent graft 2 described above can be more easily suppressed, and as a result, convenience during treatment can be further improved.
 加えて、本実施の形態では、ステントグラフト2の一部に、グラフト22およびステント21のうちの少なくともグラフト22が配置されていない、窓部20を設けるようにしたので、以下のようになる。すなわち、例えば前述した図4のように、ステントグラフト2が留置される血管(動脈9等)からの分岐部分(弓部分岐9B)に対しても、窓部20(図4の例では、窓部20内のステント21の隙間)から、血液が流れるようになる(図4中の矢印P92参照)。つまり、ステントグラフト2が留置される血管(動脈9等)の内部(図4中の矢印P91参照)に加え、そのような弓部分岐9Bに対しても、窓部20を介して血液が流れるようになる。したがって、この分岐部分の再建処置(人工血管との吻合処置等)が不要となるため、治療の際の手術時間の短縮化や、侵襲の低減を図ることが可能となる。 In addition, in the present embodiment, the stent graft 2 is partially provided with the window 20 in which at least the graft 22 out of the graft 22 and the stent 21 is not arranged. That is, for example, as shown in FIG. 4 described above, the window portion 20 (in the example of FIG. 4, the window portion 20), blood flows (see arrow P92 in FIG. 4). In other words, in addition to the inside of the blood vessel (artery 9, etc.) in which the stent graft 2 is indwelled (see arrow P91 in FIG. 4), blood can also flow through the window 20 to the arch branch 9B. become. Therefore, reconstruction treatment (anastomosis with an artificial blood vessel, etc.) for this bifurcated portion becomes unnecessary, so that it is possible to shorten the operation time and reduce invasiveness during treatment.
 また、本実施の形態では、縮径状態のステントグラフト2において、上記した窓部20の先端が、カバー31,32同士の境界Pb付近に位置しているようにしたので、以下のようになる。すなわち、上記した引っ張り操作(上記した第1および第2の引っ張り操作)によって、縮径状態のステントグラフト2がカバー31,32内から展開されて拡径する際に、上記した境界Pb付近へ向けてステントグラフト2が引っ張られることになる。したがって、このような境界Pb付近に窓部20の先端が位置していることから、拡径されたステントグラフト2が患者体内に留置される際に、窓部20の位置ずれ(軸方向への位置ずれ)が、抑制される。その結果、治療の際の利便性を、更に向上させることが可能となる。 In addition, in the present embodiment, in the stent graft 2 in a diameter-reduced state, the tip of the window portion 20 is positioned near the boundary Pb between the covers 31 and 32, so the following is the case. That is, when the diameter-reduced stent graft 2 is deployed from within the covers 31 and 32 and expanded in diameter by the above-described pulling operations (the first and second pulling operations), The stent graft 2 will be pulled. Therefore, since the tip of the window 20 is positioned near the boundary Pb, the position of the window 20 may shift (position in the axial direction) when the expanded stent graft 2 is placed in the patient's body. deviation) is suppressed. As a result, it is possible to further improve the convenience of treatment.
<2.変形例>
 続いて、上記実施の形態の変形例について説明する。なお、実施の形態における構成要素と同一のものには同一の符号を付し、適宜説明を省略する。
<2. Variation>
Next, a modification of the above embodiment will be described. In addition, the same code|symbol is attached|subjected to the same thing as the component in embodiment, and description is abbreviate|omitted suitably.
[構成]
 図7は、変形例に係る治療装置に適用されるステントグラフト(変形例に係るステントグラフト2A)の構成例を、模式的に表したものである。なお、本変形例の治療装置もまた、実施の形態で説明した治療装置4と同様に、例えばOSG法を利用した動脈解離等の治療の際に用いられる装置である。
[Constitution]
FIG. 7 schematically shows a configuration example of a stent graft (stent graft 2A according to a modification) applied to a therapeutic device according to a modification. It should be noted that, like the therapeutic device 4 described in the embodiment, the therapeutic device of this modified example is also a device that is used, for example, in the treatment of arterial dissection using the OSG method.
 本変形例の治療装置は、実施の形態の治療装置4において、ステントグラフト2の代わりに、以下説明するステントグラフト2Aを設けるようにしたものであり、他の構成(カテーテル1およびカバー3の各構成)については、同様となっている。 The treatment apparatus of this modification is provided with a stent graft 2A described below instead of the stent graft 2 in the treatment apparatus 4 of the embodiment, and has other configurations (each configuration of the catheter 1 and the cover 3). The same is true for
 図7に示したように、本変形例のステントグラフト2Aは、実施の形態のステント(図3等参照)において、ステント配置領域A1に窓部20を設けないようにしたものに対応しており、他の構成は同様となっている。つまり、このステントグラフト2Aでは、ステントグラフト2とは異なり、ステント配置領域A1の全領域において、ステント21がグラフト22から露出しないようになっている。 As shown in FIG. 7, the stent graft 2A of this modification corresponds to the stent of the embodiment (see FIG. 3, etc.) in which the window 20 is not provided in the stent placement region A1. Other configurations are the same. That is, in this stent graft 2A, unlike the stent graft 2, the stent 21 is not exposed from the graft 22 in the entire area of the stent arrangement area A1.
[作用・効果]
 このような構成の本変形例においても、基本的には、実施の形態と同様の作用により、同様の効果を得ることが可能となる。すなわち、本変形例においても、前述した2種類のカバー31,32を備えた治療装置を用いて治療を行うことで、前述した治療の際の利便性を、向上させることが可能となる。
[Action/effect]
Also in this modified example having such a configuration, basically, it is possible to obtain the same effect by the same operation as the embodiment. That is, in this modified example as well, by performing treatment using the treatment apparatus having the two types of covers 31 and 32 described above, it is possible to improve the convenience of the treatment described above.
<3.その他の変形例>
 以上、実施の形態および変形例を挙げて本発明を説明したが、本発明はこれらの実施の形態等に限定されず、種々の変形が可能である。
<3. Other modified examples>
Although the present invention has been described above with reference to the embodiments and modifications, the present invention is not limited to these embodiments and the like, and various modifications are possible.
 例えば、上記実施の形態等において説明した各部材の構成(形状や配置位置、サイズ、個数、材料等)は限定されるものではなく、他の形状や配置位置、サイズ、個数、材料等としてもよい。具体的には、上記実施の形態等では、カバー31,32の構成例を具体的に挙げて説明したが、例えば、これらのカバー31,32の構成(形状や配置位置、サイズ、個数、材料等)を、他の形状や配置位置、サイズ、個数、材料等としてもよい。詳細には、例えば、カバー31においてもカバー32と同様に、外層部と内層部と折り返し部とを有する、2層構造としてもよい。また、上記実施の形態等では、カバー31,32における端部同士が、軸方向に沿って重なり合っていない場合を例に挙げて説明したが、この場合の例には限られない。すなわち、カバー31,32が軸方向に沿って互いに分離配置されているのであれば、これらのカバー31,32における端部同士が、軸方向に沿って部分的に重なり合っているようにしてもよい。 For example, the configuration (shape, arrangement position, size, number, material, etc.) of each member described in the above embodiments and the like is not limited, and other shapes, arrangement positions, sizes, number, materials, etc. may be used. good. Specifically, in the above-described embodiment and the like, specific configuration examples of the covers 31 and 32 have been described. etc.) may be changed to other shapes, positions, sizes, numbers, materials, and the like. More specifically, for example, the cover 31 may have a two-layer structure similar to the cover 32, having an outer layer portion, an inner layer portion, and a folded portion. Also, in the above-described embodiment and the like, the case where the ends of the covers 31 and 32 do not overlap each other along the axial direction has been described as an example, but the present invention is not limited to this example. That is, if the covers 31 and 32 are arranged apart from each other along the axial direction, the ends of these covers 31 and 32 may partially overlap along the axial direction. .
 また、上記実施の形態等では、カバー32における内層部321と外層部322とが、折り返し部323を介して互いに一体化されている場合について説明したが、この場合には限られない。すなわち、例えば、カバーにおける内層部と外層部とが互いに別体になっていると共に、別体である折り返し部(連結部)によって内層部と外層部とが繋がれている(連結されている)ようにしてもよい。 In addition, in the above-described embodiment and the like, the case where the inner layer portion 321 and the outer layer portion 322 of the cover 32 are integrated with each other via the folded portion 323 has been described, but the present invention is not limited to this case. That is, for example, the inner layer portion and the outer layer portion of the cover are separated from each other, and the inner layer portion and the outer layer portion are connected (connected) by the separate folding portion (connecting portion). You may do so.
 更に、上記実施の形態等では、縮径状態のステントグラフトにおいて、窓部20の先端が、カバー31,32同士の境界Pb付近に位置している場合を例に挙げて説明したが、この例には限られない。すなわち、例えば、窓部20の先端が、そのような境界Pb付近には位置しないように、縮径状態のステントグラフトを配置するようにしてもよい。また、上記実施の形態等では、ステントグラフト2(ステント配置領域A1)の一部に、グラフト22が配置されていない窓部20を設けるようにした場合の例を挙げて説明したが、この場合の例には限られない。すなわち、例えば、ステント配置領域A1またはステント非配置領域A2の一部に、グラフト22およびステント21の双方が配置されていない、窓部を設けるようにしてもよい。 Furthermore, in the above-described embodiment and the like, the case where the distal end of the window portion 20 is positioned near the boundary Pb between the covers 31 and 32 in the stent graft in a diameter-reduced state has been described as an example. is not limited. That is, for example, the diameter-reduced stent graft may be arranged so that the tip of the window portion 20 is not positioned near such a boundary Pb. Further, in the above-described embodiment and the like, an example in which the window portion 20 in which the graft 22 is not arranged is provided in a part of the stent graft 2 (stent arrangement region A1) has been described. Examples are not limited. That is, for example, a window portion in which neither the graft 22 nor the stent 21 is arranged may be provided in a part of the stent arrangement region A1 or the stent non-arrangement region A2.
 加えて、上記実施の形態等では、ステントグラフトにおいて、カバー内で先端側に配置されるステント配置領域と、カバー内で基端側に配置されるステント非配置領域とが、それぞれ1つずつ設けられている場合の例について説明したが、この例には限られない。すなわち、例えば、ステントグラフトにおけるステント配置領域の先端側に、他のステント非配置領域が更に設けられているようにしてもよい。換言すると、ステントグラフトにおいて、2つのステント非配置領域の間に、ステント配置領域が挟まれて配置されているようにしてもよい。 In addition, in the above-described embodiments and the like, the stent graft is provided with one stent-arranged region arranged on the distal end side within the cover and a non-stent-arranged region arranged on the proximal end side within the cover. Although an example of a case in which the number of That is, for example, another non-stented region may be further provided on the distal end side of the stented region of the stent graft. In other words, in the stent graft, the stent-placed region may be sandwiched between two non-stented regions.
 また、上記実施の形態等では、治療装置を用いたステントグラフトの留置方法について、具体的に例を挙げて説明したが、このステントグラフトの留置方法については、上記実施の形態等で説明した例には限られない。具体的には、例えば上記実施の形態等では、カバー32の内層部321の基端側に対する引っ張り操作(第2の引っ張り操作)が開始された後に、カバー31の基端側に対する引っ張り操作(第1の引っ張り操作)が開始される場合の例について説明したが、この例には限られない。すなわち、例えば、上記第1および第2の引っ張り操作をそれぞれ、同時並行的に行うようにしたり、あるいは、場合によっては逆に、上記第1の引っ張り操作が開始された後に、上記第2の引っ張り操作が開始されるようにしてもよい。 In addition, in the above-described embodiments and the like, the stent graft placement method using the therapeutic device has been described with specific examples. Not limited. Specifically, for example, in the above embodiment and the like, after the pulling operation (second pulling operation) on the proximal side of the inner layer portion 321 of the cover 32 is started, the pulling operation (second pulling operation) on the proximal side of the cover 31 is performed. 1 pulling operation) has been described, but the present invention is not limited to this example. That is, for example, the first and second pulling operations are performed in parallel, respectively, or conversely, depending on the case, the second pulling operation is performed after the first pulling operation is started. An operation may be initiated.
 更に、上記実施の形態等では、カテーテルとステントグラフトとカバーとによって治療装置を構成する場合を例に挙げて説明したが、これには限られない。すなわち、例えば、カテーテルのみで治療装置を構成したり、カテーテルとステントグラフトとによって治療装置を構成したり、カテーテルとカバーとによって治療装置を構成したりするようにしてもよい。 Furthermore, in the above embodiments and the like, the case where the therapeutic device is configured by the catheter, the stent graft, and the cover has been described as an example, but the present invention is not limited to this. That is, for example, the therapeutic device may be configured with only the catheter, the therapeutic device with the catheter and the stent graft, or the therapeutic device with the catheter and the cover.
 加えて、上記実施の形態等では、主に、遠位弓部大動脈および近位下行大動脈を含む胸部大動脈についての治療に適用される、治療装置(カテーテル、ステントグラフトおよびカバー等)を例に挙げて説明したが、この例には限られない。すなわち、本発明の治療装置は、それ以外の他の動脈(例えば、上行大動脈や胸腹部大動脈、腹部大動脈、腸骨動脈、大腿動脈など)等の血管についての治療にも、適用することが可能である。 In addition, in the above embodiments and the like, treatment devices (catheters, stent grafts, covers, etc.) that are mainly applied to treatment of the thoracic aorta including the distal arch aorta and the proximal descending aorta are taken as examples. Although described, it is not limited to this example. That is, the treatment apparatus of the present invention can also be applied to treatment of blood vessels such as other arteries (for example, ascending aorta, thoracoabdominal aorta, abdominal aorta, iliac artery, femoral artery, etc.). is.

Claims (5)

  1.  軸方向に沿って延在するシャフトを有するカテーテルと、
     筒状のグラフトとステントとを含んで構成されたステントグラフトと、
     前記シャフトの先端領域において前記ステントグラフトを縮径状態にて保持するためのものであり、前記軸方向に沿って互いに分離配置されている第1および第2のカバーと
     を備え、
     前記第1のカバーは、前記軸方向に沿って前記第2のカバーの基端側に配置されており、
     前記第2のカバーは、
     前記シャフトの外周側に位置する、筒状の外層部と、
     前記外層部および前記シャフトの内周側に位置しており、前記シャフト内を介して前記カテーテルの基端側まで延在している内層部と、
     前記シャフトの先端側において、前記外層部と前記内層部とを繋ぐ折り返し部と
     を有しており、
     前記第1のカバーと前記シャフトとの間、および、前記第2のカバーにおける前記外層部と前記シャフトとの間にそれぞれ、前記ステントグラフトが前記縮径状態で保持されるようになっている
     治療装置。
    a catheter having an axially extending shaft;
    a stent graft comprising a tubular graft and a stent;
    first and second covers spaced apart from each other along the axial direction for holding the stent graft in a reduced diameter state at the distal end region of the shaft;
    The first cover is arranged on the proximal end side of the second cover along the axial direction,
    The second cover is
    a cylindrical outer layer portion positioned on the outer peripheral side of the shaft;
    an inner layer portion located on the inner peripheral side of the outer layer portion and the shaft and extending to the proximal end side of the catheter through the inside of the shaft;
    a folded portion that connects the outer layer portion and the inner layer portion on the distal end side of the shaft;
    wherein the stent graft is held in the reduced diameter state between the first cover and the shaft and between the outer layer of the second cover and the shaft, respectively. .
  2.  前記第1のカバーにおける基端側を、前記シャフトの基端方向へと引っ張る操作である、第1の引っ張り操作と、
     前記第2のカバーの前記内層部における基端側を、前記カテーテルの基端方向へと引っ張る操作である、第2の引っ張り操作と、
     がそれぞれが行われることにより、
     前記縮径状態の前記ステントグラフトが、前記第1および第2のカバー内からそれぞれ展開されて、拡径するようになっている
     請求項1に記載の治療装置。
    a first pulling operation, which is an operation of pulling the proximal side of the first cover toward the proximal direction of the shaft;
    a second pulling operation, which is an operation of pulling the proximal side of the inner layer portion of the second cover in the proximal direction of the catheter;
    are performed,
    2. The treatment device of claim 1, wherein the stent graft in the reduced diameter state is deployed from within the first and second covers, respectively, to expand.
  3.  前記第2の引っ張り操作が開始された後に、前記第1の引っ張り操作が開始されることにより、
     前記縮径状態の前記ステントグラフトが、前記第2および第1のカバー内からそれぞれ、この順序にて展開され、拡径されるようになっている
     請求項2に記載の治療装置。
    By starting the first pulling operation after the second pulling operation is started,
    3. The therapeutic device of claim 2, wherein the stent-graft in the reduced diameter state is adapted to be deployed and expanded from within the second and first covers, respectively, in that order.
  4.  前記ステントグラフトの一部に、前記グラフトおよび前記ステントのうちの少なくとも前記グラフトが配置されていない、窓部が設けられている
     請求項1ないし請求項3のいずれか1項に記載の治療装置。
    The treatment apparatus according to any one of claims 1 to 3, wherein a portion of the stent graft is provided with a window portion in which at least the graft of the graft and the stent is not arranged.
  5.  前記縮径状態の前記ステントグラフトにおいて、前記窓部の先端が、前記第1および第2のカバー同士の境界付近に位置している
     請求項4に記載の治療装置。
    5. The treatment apparatus according to claim 4, wherein in the stent graft in the diameter-reduced state, the tip of the window portion is positioned near the boundary between the first and second covers.
PCT/JP2021/025347 2021-07-05 2021-07-05 Therapeutic device WO2023281598A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2023532897A JPWO2023281598A1 (en) 2021-07-05 2021-07-05
PCT/JP2021/025347 WO2023281598A1 (en) 2021-07-05 2021-07-05 Therapeutic device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2021/025347 WO2023281598A1 (en) 2021-07-05 2021-07-05 Therapeutic device

Publications (1)

Publication Number Publication Date
WO2023281598A1 true WO2023281598A1 (en) 2023-01-12

Family

ID=84801426

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2021/025347 WO2023281598A1 (en) 2021-07-05 2021-07-05 Therapeutic device

Country Status (2)

Country Link
JP (1) JPWO2023281598A1 (en)
WO (1) WO2023281598A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006034972A (en) * 2004-07-28 2006-02-09 Cordis Corp Low disposition force type distribution apparatus
JP2011509744A (en) * 2008-01-15 2011-03-31 ゴア エンタープライズ ホールディングス,インコーポレイティド Pleated deployment sheath
US20140277367A1 (en) * 2013-03-15 2014-09-18 Altura Medical, Inc. Endograft device delivery systems and associated methods
JP2019524185A (en) * 2016-06-29 2019-09-05 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Stent delivery system

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006034972A (en) * 2004-07-28 2006-02-09 Cordis Corp Low disposition force type distribution apparatus
JP2011509744A (en) * 2008-01-15 2011-03-31 ゴア エンタープライズ ホールディングス,インコーポレイティド Pleated deployment sheath
US20140277367A1 (en) * 2013-03-15 2014-09-18 Altura Medical, Inc. Endograft device delivery systems and associated methods
JP2019524185A (en) * 2016-06-29 2019-09-05 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Stent delivery system

Also Published As

Publication number Publication date
JPWO2023281598A1 (en) 2023-01-12

Similar Documents

Publication Publication Date Title
AU768071B2 (en) Low profile stent and graft combination
US9675481B2 (en) Hybrid balloon-expandable/self-expanding prosthesis for deployment in a body vessel and method of making
WO2000042948A9 (en) Low profile stent and graft combination
WO2004103451A1 (en) Temporarily indwelled stent and stent graft
JP6200465B2 (en) Stent graft
WO2019171694A1 (en) Aorta treatment device
WO2023281598A1 (en) Therapeutic device
WO2023281599A1 (en) Treatment apparatus
JP6960544B2 (en) Treatment device
WO2018087947A1 (en) Treatment device
EP3324883B1 (en) Graft dimpling to improve crimp profile and reduce delivery forces
JP6676424B2 (en) Treatment equipment

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21949234

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2023532897

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE